| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 1.44e-32 | 46 | 160 | 21 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 2.80e-18 | 188 | 160 | 21 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 RPL22 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 ERVK-9 COL24A1 AHNAK MRPS5 PLP1 RPL5 SNTA1 SNTB1 COL1A1 COL1A2 | 1.04e-10 | 891 | 160 | 29 | GO:0005198 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.20e-07 | 49 | 160 | 7 | GO:0140359 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.87e-06 | 12 | 160 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.79e-05 | 109 | 160 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 6.38e-05 | 2 | 160 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 8.52e-05 | 56 | 160 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (acetyl-transferring) activity | 1.90e-04 | 3 | 160 | 2 | GO:0004739 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 5.87e-04 | 48 | 160 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 5.90e-04 | 178 | 160 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 7.40e-04 | 51 | 160 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 9.37e-04 | 6 | 160 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (NAD+) activity | 9.37e-04 | 6 | 160 | 2 | GO:0034604 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase [NAD(P)+] activity | 9.37e-04 | 6 | 160 | 2 | GO:0034603 | |
| GeneOntologyMolecularFunction | biotin binding | 9.37e-04 | 6 | 160 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase activity | 9.37e-04 | 6 | 160 | 2 | GO:0004738 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 1.31e-03 | 7 | 160 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 ABCA13 EIF2S3B RRAS ABCA10 ABCC6 DDX1 EIF2S3 ABCC8 RAB40C ABCC12 GFM1 HSPA7 ABCG8 AGAP2 | 1.45e-03 | 775 | 160 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.73e-03 | 8 | 160 | 2 | GO:0015431 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 CARMIL2 COL27A1 COL5A3 EGFL6 COL24A1 COL1A1 COL1A2 | 1.47e-11 | 377 | 160 | 20 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 CARMIL2 COL27A1 COL5A3 EGFL6 COL24A1 COL1A1 COL1A2 | 1.54e-11 | 378 | 160 | 20 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 CARMIL2 COL27A1 COL5A3 EGFL6 COL24A1 COL1A1 COL1A2 | 1.61e-11 | 379 | 160 | 20 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL1A1 COL1A2 | 7.41e-09 | 76 | 160 | 9 | GO:0030199 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.64e-06 | 12 | 160 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 9.80e-06 | 18 | 160 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 5.98e-05 | 2 | 160 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 1.61e-04 | 198 | 160 | 8 | GO:0007605 | |
| GeneOntologyBiologicalProcess | skin morphogenesis | 1.95e-04 | 15 | 160 | 3 | GO:0043589 | |
| GeneOntologyBiologicalProcess | acyl-CoA metabolic process | 2.08e-04 | 109 | 160 | 6 | GO:0006637 | |
| GeneOntologyBiologicalProcess | thioester metabolic process | 2.08e-04 | 109 | 160 | 6 | GO:0035383 | |
| GeneOntologyBiologicalProcess | acetyl-CoA metabolic process | 2.32e-04 | 39 | 160 | 4 | GO:0006084 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 C1QTNF9B COL5A3 COL6A5 COLEC11 COL24A1 FCN2 C1QTNF9 C1QTNF1 MARCO COL1A1 COL1A2 | 2.40e-36 | 88 | 162 | 27 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL1A1 COL1A2 | 4.30e-23 | 21 | 162 | 13 | GO:0098644 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL1A1 COL1A2 | 1.74e-17 | 12 | 162 | 9 | GO:0005583 |
| GeneOntologyCellularComponent | banded collagen fibril | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL1A1 COL1A2 | 1.74e-17 | 12 | 162 | 9 | GO:0098643 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 IL16 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 HNRNPM COL5A3 COL6A5 EGFL6 COL24A1 FCN2 PLOD1 MARCO COL1A1 COL1A2 | 7.37e-15 | 530 | 162 | 27 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 IL16 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 HNRNPM COL5A3 COL6A5 EGFL6 COL24A1 FCN2 PLOD1 MARCO COL1A1 COL1A2 | 1.19e-12 | 656 | 162 | 27 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 IL16 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 HNRNPM COL5A3 COL6A5 EGFL6 COL24A1 FCN2 PLOD1 MARCO COL1A1 COL1A2 | 1.28e-12 | 658 | 162 | 27 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL4A3 COL4A4 PCSK2 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 1.44e-12 | 332 | 162 | 20 | GO:0005788 |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.63e-11 | 5 | 162 | 5 | GO:0005592 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.44e-09 | 8 | 162 | 5 | GO:0098651 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 5.15e-08 | 6 | 162 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.37e-07 | 8 | 162 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.37e-07 | 8 | 162 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type V trimer | 1.82e-06 | 4 | 162 | 3 | GO:0005588 | |
| GeneOntologyCellularComponent | basement membrane | 4.98e-06 | 122 | 162 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL4A3 COL4A4 CACNA1C COL4A5 COL4A6 COL5A1 COL5A2 FLNA FLNC COL11A1 COL11A2 COL27A1 APC2 COL5A3 CHMP2A SYNJ2 AHNAK NINL TPPP3 TNNT1 COL1A1 COL1A2 | 4.54e-05 | 1187 | 162 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type I trimer | 5.97e-05 | 2 | 162 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 3.54e-04 | 4 | 162 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | GAIT complex | 3.54e-04 | 4 | 162 | 2 | GO:0097452 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SART3 BCL9L FLNA GPATCH1 POLR2B SNRNP35 HNRNPM CHMP2A ASH2L KMT2D MED4 NOP14 CBX6 WDR6 CTR9 DBF4 MEPCE NFYB SUGP1 BRD1 TAF13 HSPA7 SYNCRIP | 4.03e-04 | 1377 | 162 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | anchoring junction | RPL22 FLNA FLNC IL16 COL13A1 CARMIL2 TRIOBP PARD3B RRAS CDC42BPB AHNAK CGN TJP2 PATJ RPL5 SNTA1 SNTB1 PDZD2 | 5.81e-04 | 976 | 162 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | sarcolemma | 7.15e-04 | 190 | 162 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 8.77e-04 | 6 | 162 | 2 | GO:0005850 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 8.77e-04 | 6 | 162 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | glycoprotein complex | 9.27e-04 | 25 | 162 | 3 | GO:0090665 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.22e-03 | 7 | 162 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | pyruvate dehydrogenase complex | 1.62e-03 | 8 | 162 | 2 | GO:0045254 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.62e-03 | 8 | 162 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL2A1 CACNA1C COL5A1 COL5A2 FLNA FLNC COL11A1 COL11A2 COL27A1 APC2 COL5A3 CHMP2A SYNJ2 AHNAK NINL TPPP3 TNNT1 COL1A1 COL1A2 | 2.00e-03 | 1179 | 162 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | mitochondrial matrix | HSPE1 ACACB PDHA1 PDHA2 ETFA SUCLA2 HIBCH MRPS5 ALDH2 GFM1 ALDH5A1 | 2.60e-03 | 523 | 162 | 11 | GO:0005759 |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.74e-03 | 12 | 162 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | aminoacyl-tRNA synthetase multienzyme complex | 3.74e-03 | 12 | 162 | 2 | GO:0017101 | |
| HumanPheno | Arterial rupture | 1.34e-08 | 8 | 63 | 5 | HP:0025019 | |
| HumanPheno | Shoulder dislocation | 9.51e-08 | 20 | 63 | 6 | HP:0003834 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.05e-07 | 5 | 63 | 4 | HP:0007964 | |
| HumanPheno | Atrophic scars | 2.42e-07 | 37 | 63 | 7 | HP:0001075 | |
| HumanPheno | Molluscoid pseudotumors | 7.23e-07 | 7 | 63 | 4 | HP:0000993 | |
| HumanPheno | Myopia | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 FLNA AARS1 COL9A1 COL11A1 COL11A2 APC2 POGZ TUB AHDC1 ABCC6 EIF2S3 PLOD1 COL1A2 | 9.16e-07 | 447 | 63 | 19 | HP:0000545 |
| HumanPheno | Osteoarthritis | 1.01e-06 | 65 | 63 | 8 | HP:0002758 | |
| HumanPheno | Anterior lenticonus | 1.80e-06 | 3 | 63 | 3 | HP:0011501 | |
| HumanPheno | Glomerular basement membrane lamellation | 1.80e-06 | 3 | 63 | 3 | HP:0030034 | |
| HumanPheno | Subcutaneous spheroids | 1.80e-06 | 3 | 63 | 3 | HP:0025014 | |
| HumanPheno | Hip dislocation | COL2A1 COL5A1 COL5A2 FLNA COL6A2 AARS1 COL13A1 COL27A1 COLEC11 KMT2D PLCH1 PLOD1 COL1A1 COL1A2 | 2.59e-06 | 263 | 63 | 14 | HP:0002827 |
| HumanPheno | Atypical scarring of skin | 2.76e-06 | 74 | 63 | 8 | HP:0000987 | |
| HumanPheno | Lenticonus | 4.22e-06 | 10 | 63 | 4 | HP:0001142 | |
| HumanPheno | Cigarette-paper scars | 4.22e-06 | 10 | 63 | 4 | HP:0001073 | |
| HumanPheno | Cervical insufficiency | 7.15e-06 | 4 | 63 | 3 | HP:0030009 | |
| HumanPheno | Piezogenic pedal papules | 7.15e-06 | 4 | 63 | 3 | HP:0025509 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 7.15e-06 | 4 | 63 | 3 | HP:0010590 | |
| HumanPheno | Incisional hernia | 7.15e-06 | 4 | 63 | 3 | HP:0004872 | |
| HumanPheno | Arterial dissection | 9.77e-06 | 12 | 63 | 4 | HP:0005294 | |
| HumanPheno | Abnormal hip joint morphology | COL2A1 GABRD COL5A1 COL5A2 FLNA COL6A2 AARS1 COL13A1 COL27A1 APC2 ABCC6 COLEC11 KMT2D PLCH1 TNNT1 PLOD1 COL1A1 COL1A2 | 1.54e-05 | 490 | 63 | 18 | HP:0001384 |
| HumanPheno | Mitral valve prolapse | 1.64e-05 | 123 | 63 | 9 | HP:0001634 | |
| HumanPheno | Abnormal hip bone morphology | COL2A1 GABRD COL5A1 COL5A2 FLNA COL6A2 AARS1 COL9A1 COL11A1 COL11A2 COL13A1 COL27A1 APC2 ABCC6 COLEC11 KMT2D PLCH1 TNNT1 PLOD1 COL1A1 COL1A2 | 1.91e-05 | 653 | 63 | 21 | HP:0003272 |
| HumanPheno | Tricuspid valve prolapse | 1.94e-05 | 14 | 63 | 4 | HP:0001704 | |
| HumanPheno | Soft, doughy skin | 1.94e-05 | 14 | 63 | 4 | HP:0001027 | |
| HumanPheno | Depressed nasal tip | 1.94e-05 | 28 | 63 | 5 | HP:0000437 | |
| HumanPheno | Abnormal synovial membrane morphology | COL2A1 GABRD COL5A1 COL5A2 FLNA COL6A2 AARS1 COL13A1 COL27A1 APC2 ABCC6 COLEC11 KMT2D PLCH1 TNNT1 PLOD1 COL1A1 COL1A2 | 2.21e-05 | 503 | 63 | 18 | HP:0005262 |
| HumanPheno | Lower extremity joint dislocation | COL2A1 COL5A1 COL5A2 FLNA COL6A2 AARS1 COL13A1 COL27A1 COLEC11 KMT2D PLCH1 PLOD1 COL1A1 COL1A2 | 2.34e-05 | 318 | 63 | 14 | HP:0030311 |
| HumanPheno | Joint hypermobility | COL2A1 COL5A1 COL5A2 FLNA COL6A2 COL9A1 COL11A1 COL13A1 APC2 POGZ RRAS CDC42BPB AHDC1 ABCC6 COLEC11 KMT2D PLOD1 COL1A1 COL1A2 | 2.41e-05 | 557 | 63 | 19 | HP:0001382 |
| HumanPheno | Scarring | 3.06e-05 | 102 | 63 | 8 | HP:0100699 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL2A1 GABRD COL5A1 COL5A2 FLNA COL6A2 FLNC AARS1 COL9A1 COL11A1 COL11A2 COL13A1 COL27A1 APC2 ABCC6 COLEC11 KMT2D PLCH1 TNNT1 PLOD1 COL1A1 COL1A2 | 3.15e-05 | 730 | 63 | 22 | HP:0002644 |
| HumanPheno | Gastroesophageal reflux | COL2A1 GABRD CACNA1C COL4A5 COL4A6 COL5A1 COL5A2 FLNA AARS1 COL13A1 PDHA1 APC2 POGZ SUCLA2 SH2B1 KMT2D PLCH1 COL1A1 | 3.22e-05 | 517 | 63 | 18 | HP:0002020 |
| HumanPheno | Joint subluxation | 3.27e-05 | 31 | 63 | 5 | HP:0032153 | |
| HumanPheno | Mild myopia | 3.51e-05 | 6 | 63 | 3 | HP:0025573 | |
| HumanPheno | Abnormal shoulder morphology | PLIN4 COL5A1 COL5A2 FLNA COL6A2 FLNC COL13A1 ABCC6 TNNT1 PLOD1 COL1A1 COL1A2 | 3.64e-05 | 246 | 63 | 12 | HP:0003043 |
| HumanPheno | Dermal atrophy | 4.33e-05 | 107 | 63 | 8 | HP:0004334 | |
| HumanPheno | Bell-shaped thorax | 4.48e-05 | 33 | 63 | 5 | HP:0001591 | |
| HumanPheno | Premature rupture of membranes | 4.48e-05 | 17 | 63 | 4 | HP:0001788 | |
| HumanPheno | Joint laxity | 5.08e-05 | 55 | 63 | 6 | HP:0001388 | |
| HumanPheno | Abnormal mitral valve morphology | COL2A1 COL5A1 COL5A2 FLNA FLNC ABCC6 KMT2D PLOD1 RPL5 ABCG8 COL1A1 COL1A2 | 5.60e-05 | 257 | 63 | 12 | HP:0001633 |
| HumanPheno | Abnormality of lens shape | 5.71e-05 | 18 | 63 | 4 | HP:0011526 | |
| HumanPheno | Abnormal mitral valve physiology | COL5A1 COL5A2 FLNA FLNC ABCC6 KMT2D RPL5 ABCG8 COL1A1 COL1A2 | 5.94e-05 | 180 | 63 | 10 | HP:0031481 |
| HumanPheno | Pulp calcification | 6.09e-05 | 7 | 63 | 3 | HP:0003771 | |
| HumanPheno | Phalangeal dislocation | 6.09e-05 | 7 | 63 | 3 | HP:0006243 | |
| HumanPheno | Dumbbell-shaped long bone | 6.09e-05 | 7 | 63 | 3 | HP:0000947 | |
| HumanPheno | Uterine prolapse | 6.09e-05 | 7 | 63 | 3 | HP:0000139 | |
| HumanPheno | Abnormality of upper limb joint | COL2A1 GABRD PLIN4 COL5A1 COL5A2 FLNA COL6A2 FLNC COL9A1 COL11A1 COL11A2 COL13A1 COL27A1 APC2 RRAS ABCC6 COLEC11 TNNT1 PLOD1 COL1A1 COL1A2 | 6.15e-05 | 705 | 63 | 21 | HP:0009810 |
| HumanPheno | Limb pain | 6.23e-05 | 57 | 63 | 6 | HP:0009763 | |
| HumanPheno | Abnormal mitral valve morphology | 6.45e-05 | 146 | 63 | 9 | HP:0031477 | |
| HumanPheno | Abnormality of refraction | COL2A1 GABRD COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 EPRS1 FLNA AARS1 COL9A1 COL11A1 COL11A2 APC2 POGZ TUB AHDC1 ABCC6 EIF2S3 PLOD1 COL1A2 | 6.70e-05 | 709 | 63 | 21 | HP:0000539 |
| HumanPheno | Bladder diverticulum | 6.91e-05 | 36 | 63 | 5 | HP:0000015 | |
| HumanPheno | Fragile skin | 7.92e-05 | 37 | 63 | 5 | HP:0001030 | |
| HumanPheno | Abnormal knee physiology | 8.47e-05 | 87 | 63 | 7 | HP:0034670 | |
| HumanPheno | Sensorineural hearing impairment | COL2A1 GABRD COL4A3 COL4A5 COL4A6 EPRS1 FLNA AARS1 COL9A1 COL11A1 COL11A2 COL13A1 COL27A1 TRIOBP POGZ RRAS SUCLA2 CDC42BPB TUB ABCC6 SH2B1 KMT2D GATAD1 PLCH1 HSD17B4 | 8.57e-05 | 958 | 63 | 25 | HP:0000407 |
| HumanPheno | Genital hernia | 9.66e-05 | 8 | 63 | 3 | HP:0100823 | |
| HumanPheno | Blepharochalasis | 9.66e-05 | 8 | 63 | 3 | HP:0010749 | |
| HumanPheno | Abnormality of the inner ear | COL2A1 GABRD COL4A3 COL4A5 COL4A6 EPRS1 FLNA AARS1 COL9A1 COL11A1 COL11A2 COL13A1 COL27A1 TRIOBP POGZ RRAS SUCLA2 CDC42BPB TUB ABCC6 SH2B1 KMT2D GATAD1 PLCH1 HSD17B4 COL1A1 COL1A2 | 1.16e-04 | 1102 | 63 | 27 | HP:0000359 |
| HumanPheno | Platyspondyly | 1.24e-04 | 124 | 63 | 8 | HP:0000926 | |
| HumanPheno | Tibial bowing | 1.31e-04 | 41 | 63 | 5 | HP:0002982 | |
| HumanPheno | Vitreoretinopathy | 1.32e-04 | 22 | 63 | 4 | HP:0007773 | |
| HumanPheno | Abnormal cranial suture/fontanelle morphology | GABRD FLNA AARS1 COL11A1 COL11A2 APC2 ETFA POGZ AHDC1 SH2B1 COLEC11 KMT2D ABCC8 HSD17B4 COL1A1 COL1A2 | 1.38e-04 | 472 | 63 | 16 | HP:0000235 |
| HumanPheno | Enlarged thorax | 1.39e-04 | 94 | 63 | 7 | HP:0100625 | |
| HumanPheno | Absent ossification of calvaria | 1.51e-04 | 2 | 63 | 2 | HP:0005623 | |
| HumanPheno | Dyspepsia | 1.51e-04 | 2 | 63 | 2 | HP:0410281 | |
| HumanPheno | Severe generalized osteoporosis | 1.51e-04 | 2 | 63 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 1.51e-04 | 2 | 63 | 2 | HP:0005005 | |
| HumanPheno | Biconcave flattened vertebrae | 1.51e-04 | 2 | 63 | 2 | HP:0003321 | |
| HumanPheno | Irregular distal femoral epiphysis | 1.51e-04 | 2 | 63 | 2 | HP:0006407 | |
| HumanPheno | Schmorl's node | 1.51e-04 | 2 | 63 | 2 | HP:0030041 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 1.51e-04 | 2 | 63 | 2 | HP:0006524 | |
| HumanPheno | Diffuse leiomyomatosis | 1.51e-04 | 2 | 63 | 2 | HP:0006756 | |
| HumanPheno | Mitral regurgitation | 1.51e-04 | 163 | 63 | 9 | HP:0001653 | |
| HumanPheno | Upper extremity joint dislocation | 1.58e-04 | 96 | 63 | 7 | HP:0030310 | |
| HumanPheno | Abnormal esophagus physiology | COL2A1 GABRD PLIN4 CACNA1C COL4A5 COL4A6 COL5A1 EPRS1 COL5A2 FLNA FLNC AARS1 COL13A1 CARMIL2 PDHA1 APC2 POGZ SUCLA2 SH2B1 KMT2D PLCH1 TNNT1 PLP1 COL1A1 | 1.63e-04 | 933 | 63 | 24 | HP:0025270 |
| HumanPheno | Abnormal thorax morphology | COL2A1 GABRD PLIN4 COL4A5 COL4A6 COL5A1 COL5A2 FLNA COL6A2 FLNC AARS1 COL11A1 COL11A2 COL13A1 APC2 POGZ NHLRC2 RRAS CDC42BPB ABCC6 SH2B1 COLEC11 KMT2D ABCC8 HSD17B4 TNNT1 PLOD1 RPL5 COL1A1 COL1A2 | 1.76e-04 | 1328 | 63 | 30 | HP:0000765 |
| HumanPheno | Abnormal vertebral morphology | COL2A1 FLNA COL9A1 COL11A1 COL11A2 MNX1 APC2 POGZ ABCC6 SH2B1 COLEC11 KMT2D HIBCH PLOD1 COL1A1 COL1A2 | 1.80e-04 | 483 | 63 | 16 | HP:0003468 |
| HumanPheno | Small joint hypermobilty | 1.83e-04 | 69 | 63 | 6 | HP:0430046 | |
| HumanPheno | Soft skin | 1.85e-04 | 44 | 63 | 5 | HP:0000977 | |
| HumanPheno | Midface retrusion | COL2A1 GABRD FLNA COL11A1 COL11A2 COL27A1 POGZ RRAS SH2B1 KMT2D PLP1 COL1A1 | 1.85e-04 | 291 | 63 | 12 | HP:0011800 |
| HumanPheno | Irregular femoral epiphysis | 2.03e-04 | 10 | 63 | 3 | HP:0006361 | |
| HumanPheno | Abnormality of cranial sutures | GABRD FLNA AARS1 COL11A1 APC2 POGZ AHDC1 SH2B1 COLEC11 KMT2D ABCC8 HSD17B4 COL1A1 COL1A2 | 2.06e-04 | 388 | 63 | 14 | HP:0011329 |
| HumanPheno | Joint dislocation | COL2A1 COL5A1 COL5A2 FLNA COL6A2 AARS1 COL13A1 COL27A1 COLEC11 KMT2D PLCH1 PLOD1 COL1A1 COL1A2 | 2.18e-04 | 390 | 63 | 14 | HP:0001373 |
| HumanPheno | Neck flexor weakness | 2.29e-04 | 46 | 63 | 5 | HP:0003722 | |
| HumanPheno | Motor delay | COL2A1 CACNA1C COL5A1 EPRS1 COL5A2 FLNA COL6A2 COL13A1 APC2 POGZ NHLRC2 SUCLA2 AHDC1 SH2B1 KMT2D HIBCH ABCC8 HSD17B4 TNNT1 GFM1 PLOD1 PLP1 ALDH5A1 COL1A1 COL1A2 | 2.37e-04 | 1018 | 63 | 25 | HP:0001270 |
| HumanPheno | Vascular dilatation | GABRD COL5A1 COL5A2 FLNA MNX1 APC2 ABCC6 PLOD1 COL1A1 COL1A2 | 2.61e-04 | 215 | 63 | 10 | HP:0002617 |
| HumanPheno | Abnormal atrioventricular valve physiology | COL5A1 COL5A2 FLNA FLNC ABCC6 KMT2D RPL5 ABCG8 COL1A1 COL1A2 | 2.61e-04 | 215 | 63 | 10 | HP:0031650 |
| HumanPheno | Abnormal joint physiology | COL2A1 GABRD CACNA1C COL5A1 COL5A2 FLNA COL6A2 FLNC AARS1 COL9A1 COL11A1 COL11A2 COL13A1 PDHA1 COL27A1 APC2 POGZ RRAS CDC42BPB AHDC1 ABCC6 COLEC11 KMT2D ABCC8 PLCH1 TNNT1 PLOD1 PLP1 COL1A1 COL1A2 | 2.70e-04 | 1358 | 63 | 30 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | COL2A1 GABRD CACNA1C COL5A1 COL5A2 FLNA COL6A2 FLNC AARS1 COL9A1 COL11A1 COL11A2 COL13A1 PDHA1 COL27A1 APC2 POGZ RRAS CDC42BPB AHDC1 ABCC6 COLEC11 KMT2D ABCC8 PLCH1 TNNT1 PLOD1 PLP1 COL1A1 COL1A2 | 2.70e-04 | 1358 | 63 | 30 | HP:0011729 |
| HumanPheno | Abnormal tricuspid valve morphology | 2.77e-04 | 105 | 63 | 7 | HP:0031440 | |
| HumanPheno | Generalized joint hypermobility | 2.80e-04 | 48 | 63 | 5 | HP:0002761 | |
| HumanPheno | Abnormal morphology of the radius | COL2A1 COL5A1 COL5A2 FLNA COL9A1 COL11A1 COL27A1 RRAS COLEC11 COL1A1 | 2.81e-04 | 217 | 63 | 10 | HP:0002818 |
| HumanPheno | Abnormal tibia morphology | 3.12e-04 | 107 | 63 | 7 | HP:0002992 | |
| HumanPheno | Feeding difficulties | COL2A1 GABRD COL4A5 COL4A6 EPRS1 FLNA AARS1 COL13A1 PDHA1 APC2 POGZ NHLRC2 RRAS SUCLA2 CDC42BPB AHDC1 ABCC6 SH2B1 KMT2D HIBCH ABCC8 PLCH1 HSD17B4 TNNT1 GFM1 PLP1 COL1A1 | 3.24e-04 | 1168 | 63 | 27 | HP:0011968 |
| HumanPheno | Abnormal scapula morphology | 3.34e-04 | 181 | 63 | 9 | HP:0000782 | |
| HumanPheno | Abnormal patella morphology | 3.49e-04 | 109 | 63 | 7 | HP:0003045 | |
| HumanPheno | Thickened glomerular basement membrane | 3.66e-04 | 12 | 63 | 3 | HP:0004722 | |
| HumanPheno | Dermatochalasis | 3.66e-04 | 12 | 63 | 3 | HP:0010750 | |
| HumanPheno | Arteriovenous fistula | 3.66e-04 | 12 | 63 | 3 | HP:0004947 | |
| HumanPheno | Obstructive sleep apnea | 3.86e-04 | 79 | 63 | 6 | HP:0002870 | |
| HumanPheno | Abnormal aortic morphology | GABRD COL5A1 COL5A2 FLNA APC2 RRAS ABCC6 KMT2D PLOD1 RPL5 ABCG8 COL1A1 COL1A2 | 3.91e-04 | 363 | 63 | 13 | HP:0030963 |
| HumanPheno | Thin ribs | 4.09e-04 | 52 | 63 | 5 | HP:0000883 | |
| MousePheno | abnormal inner ear morphology | COL4A3 COL9A1 COL11A1 COL11A2 SLC4A7 SFSWAP TRIOBP TUB SLC7A8 KMT2D MCTP1 SYNJ2 | 3.99e-05 | 303 | 136 | 12 | MP:0000026 |
| MousePheno | impaired hearing | COL2A1 COL4A3 COL4A4 COL9A1 COL11A2 TRIOBP TUB SLC7A8 SYNJ2 COL1A1 | 6.43e-05 | 223 | 136 | 10 | MP:0006325 |
| MousePheno | abnormal knee joint morphology | 7.25e-05 | 9 | 136 | 3 | MP:0030837 | |
| MousePheno | abnormal limb joint morphology | 9.25e-05 | 25 | 136 | 4 | MP:0030805 | |
| MousePheno | abnormal cochlear labyrinth morphology | COL4A3 COL9A1 COL11A1 COL11A2 SLC4A7 TRIOBP TUB SLC7A8 MCTP1 SYNJ2 | 9.95e-05 | 235 | 136 | 10 | MP:0004426 |
| MousePheno | abnormal scala media morphology | COL4A3 COL9A1 COL11A1 COL11A2 SLC4A7 TRIOBP TUB SLC7A8 MCTP1 SYNJ2 | 9.95e-05 | 235 | 136 | 10 | MP:0003169 |
| MousePheno | increased or absent threshold for auditory brainstem response | COL4A3 COL4A4 COL9A1 COL11A2 SLC4A7 TRIOBP TUB SLC7A8 MCTP1 SYNJ2 | 1.03e-04 | 236 | 136 | 10 | MP:0011967 |
| MousePheno | abnormal cutaneous collagen fibril morphology | 1.26e-04 | 27 | 136 | 4 | MP:0008438 | |
| MousePheno | abnormal cochlea morphology | COL4A3 COL9A1 COL11A1 COL11A2 SLC4A7 TRIOBP TUB SLC7A8 MCTP1 SYNJ2 | 1.55e-04 | 248 | 136 | 10 | MP:0000031 |
| MousePheno | abnormal hearing physiology | COL2A1 PLIN4 COL4A3 COL4A4 COL9A1 COL11A1 COL11A2 SLC4A7 TRIOBP TUB SLC7A8 MCTP1 SYNJ2 CSNK1G3 HSD17B4 SYNCRIP COL1A1 | 1.66e-04 | 643 | 136 | 17 | MP:0001963 |
| MousePheno | abnormal ear morphology | COL4A3 COL9A1 COL11A1 COL11A2 SLC4A7 SFSWAP TRIOBP HMX1 TUB SLC7A8 KMT2D MCTP1 SYNJ2 COL1A1 | 1.95e-04 | 470 | 136 | 14 | MP:0002102 |
| MousePheno | abnormal membranous labyrinth morphology | COL4A3 COL9A1 COL11A1 COL11A2 SLC4A7 TRIOBP TUB SLC7A8 MCTP1 SYNJ2 | 2.41e-04 | 262 | 136 | 10 | MP:0000035 |
| Domain | Collagen | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 C1QTNF9B COL5A3 COL6A5 COLEC11 COL24A1 FCN2 C1QTNF9 C1QTNF1 MARCO COL1A1 COL1A2 | 1.13e-35 | 85 | 160 | 27 | IPR008160 |
| Domain | Collagen | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 C1QTNF9B COL5A3 COL6A5 COLEC11 COL24A1 FCN2 C1QTNF9 C1QTNF1 MARCO COL1A1 COL1A2 | 1.13e-35 | 85 | 160 | 27 | PF01391 |
| Domain | NC1_FIB | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 1.75e-20 | 11 | 160 | 10 | PS51461 |
| Domain | Fib_collagen_C | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 1.75e-20 | 11 | 160 | 10 | PD002078 |
| Domain | Fib_collagen_C | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 1.75e-20 | 11 | 160 | 10 | IPR000885 |
| Domain | COLFI | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 1.75e-20 | 11 | 160 | 10 | PF01410 |
| Domain | COLFI | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 1.75e-20 | 11 | 160 | 10 | SM00038 |
| Domain | TSPN | COL5A1 COL9A1 COL11A1 COL11A2 COL15A1 COL16A1 COL27A1 COL5A3 COL24A1 | 1.46e-13 | 23 | 160 | 9 | SM00210 |
| Domain | Laminin_G | COL5A1 COL9A1 COL11A1 COL11A2 COL15A1 COL16A1 COL27A1 COL5A3 COL24A1 NRXN3 | 5.88e-11 | 58 | 160 | 10 | IPR001791 |
| Domain | ConA-like_dom | COL5A1 COL9A1 NPTX1 NPTX2 COL11A1 COL11A2 COL15A1 COL16A1 COL27A1 COL5A3 ASH2L DDX1 EGFL6 COL24A1 NRXN3 | 6.74e-10 | 219 | 160 | 15 | IPR013320 |
| Domain | - | COL5A1 COL9A1 NPTX1 NPTX2 COL11A1 COL11A2 COL16A1 COL5A3 COL24A1 NRXN3 | 8.68e-09 | 95 | 160 | 10 | 2.60.120.200 |
| Domain | C4 | 7.68e-08 | 6 | 160 | 4 | SM00111 | |
| Domain | Collagen_VI_NC | 7.68e-08 | 6 | 160 | 4 | IPR001442 | |
| Domain | NC1_IV | 7.68e-08 | 6 | 160 | 4 | PS51403 | |
| Domain | - | 7.68e-08 | 6 | 160 | 4 | 2.170.240.10 | |
| Domain | C4 | 7.68e-08 | 6 | 160 | 4 | PF01413 | |
| Domain | ABC_tran | 1.63e-07 | 48 | 160 | 7 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.63e-07 | 48 | 160 | 7 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.88e-07 | 49 | 160 | 7 | PS00211 | |
| Domain | ABC_transporter-like | 2.18e-07 | 50 | 160 | 7 | IPR003439 | |
| Domain | Laminin_G_2 | 1.09e-06 | 40 | 160 | 6 | PF02210 | |
| Domain | ABC_transporter_CS | 1.46e-06 | 42 | 160 | 6 | IPR017871 | |
| Domain | LamG | 1.94e-06 | 44 | 160 | 6 | SM00282 | |
| Domain | PDZ | 3.54e-06 | 141 | 160 | 9 | PF00595 | |
| Domain | PDZ | 5.26e-06 | 148 | 160 | 9 | SM00228 | |
| Domain | - | 5.87e-06 | 150 | 160 | 9 | 2.30.42.10 | |
| Domain | PDZ | 6.20e-06 | 151 | 160 | 9 | PS50106 | |
| Domain | PDZ | 6.54e-06 | 152 | 160 | 9 | IPR001478 | |
| Domain | SURP | 1.21e-05 | 6 | 160 | 3 | PS50128 | |
| Domain | Surp | 1.21e-05 | 6 | 160 | 3 | PF01805 | |
| Domain | SWAP | 1.21e-05 | 6 | 160 | 3 | SM00648 | |
| Domain | Surp | 1.21e-05 | 6 | 160 | 3 | IPR000061 | |
| Domain | ABC_membrane | 4.82e-05 | 24 | 160 | 4 | PF00664 | |
| Domain | ACC_central | 7.29e-05 | 2 | 160 | 2 | PF08326 | |
| Domain | AcCoA_COase_cen | 7.29e-05 | 2 | 160 | 2 | IPR013537 | |
| Domain | Pyrv_DH_E1_asu_subgrp-y | 7.29e-05 | 2 | 160 | 2 | IPR017597 | |
| Domain | ABC_TM1F | 9.05e-05 | 28 | 160 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 9.05e-05 | 28 | 160 | 4 | IPR011527 | |
| Domain | ATP_GRASP | 2.10e-04 | 14 | 160 | 3 | PS50975 | |
| Domain | ATP-grasp | 2.10e-04 | 14 | 160 | 3 | IPR011761 | |
| Domain | - | 2.60e-04 | 15 | 160 | 3 | 3.30.1490.20 | |
| Domain | Cadherin_tail | 2.75e-04 | 37 | 160 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 2.75e-04 | 37 | 160 | 4 | IPR031904 | |
| Domain | LAM_G_DOMAIN | 3.05e-04 | 38 | 160 | 4 | PS50025 | |
| Domain | CTDL_fold | 3.19e-04 | 107 | 160 | 6 | IPR016187 | |
| Domain | Carboxyl_trans | 4.33e-04 | 4 | 160 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 4.33e-04 | 4 | 160 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 4.33e-04 | 4 | 160 | 2 | PS50980 | |
| Domain | COA_CT_N | 4.33e-04 | 4 | 160 | 2 | IPR011762 | |
| Domain | COA_CT_C | 4.33e-04 | 4 | 160 | 2 | IPR011763 | |
| Domain | Multidrug-R_assoc | 4.33e-04 | 4 | 160 | 2 | IPR005292 | |
| Domain | Carboxyl_trans | 4.33e-04 | 4 | 160 | 2 | IPR000022 | |
| Domain | Cadherin_C | 4.51e-04 | 42 | 160 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 4.51e-04 | 42 | 160 | 4 | PF16492 | |
| Domain | ATP_grasp_subdomain_1 | 4.58e-04 | 18 | 160 | 3 | IPR013815 | |
| Domain | - | 4.58e-04 | 18 | 160 | 3 | 3.30.470.20 | |
| Domain | - | ABCC3 ABCA13 PFKFB2 RRAS ABCA10 ABCC6 DDX1 EIF2S3 ABCC8 TJP2 RAB40C ABCC12 CHST2 GFM1 ABCG8 AGAP2 | 6.87e-04 | 746 | 160 | 16 | 3.40.50.300 |
| Domain | Biotin_BS | 7.17e-04 | 5 | 160 | 2 | IPR001882 | |
| Domain | Biotin_COase_C | 7.17e-04 | 5 | 160 | 2 | IPR005482 | |
| Domain | Syntrophin | 7.17e-04 | 5 | 160 | 2 | IPR015482 | |
| Domain | BC | 7.17e-04 | 5 | 160 | 2 | PS50979 | |
| Domain | Biotin_carb_C | 7.17e-04 | 5 | 160 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 7.17e-04 | 5 | 160 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 7.17e-04 | 5 | 160 | 2 | IPR011764 | |
| Domain | CPSASE_1 | 7.17e-04 | 5 | 160 | 2 | PS00866 | |
| Domain | Pentaxin_CS | 7.17e-04 | 5 | 160 | 2 | IPR030476 | |
| Domain | BIOTIN | 7.17e-04 | 5 | 160 | 2 | PS00188 | |
| Domain | - | 7.33e-04 | 21 | 160 | 3 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 7.33e-04 | 21 | 160 | 3 | IPR029045 | |
| Domain | G_PATCH | 9.63e-04 | 23 | 160 | 3 | PS50174 | |
| Domain | G_patch | 9.63e-04 | 23 | 160 | 3 | SM00443 | |
| Domain | G_patch_dom | 9.63e-04 | 23 | 160 | 3 | IPR000467 | |
| Domain | G-patch | 9.63e-04 | 23 | 160 | 3 | PF01585 | |
| Domain | E1_dh | 1.07e-03 | 6 | 160 | 2 | PF00676 | |
| Domain | Rudment_hybrid_motif | 1.07e-03 | 6 | 160 | 2 | IPR011054 | |
| Domain | DH_E1 | 1.07e-03 | 6 | 160 | 2 | IPR001017 | |
| Domain | CPSASE_2 | 1.07e-03 | 6 | 160 | 2 | PS00867 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.49e-03 | 7 | 160 | 2 | IPR005479 | |
| Domain | BC-like_N | 1.49e-03 | 7 | 160 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 1.49e-03 | 7 | 160 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 1.49e-03 | 7 | 160 | 2 | PF00289 | |
| Domain | AAA | 1.52e-03 | 144 | 160 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.52e-03 | 144 | 160 | 6 | IPR003593 | |
| Domain | Transl_B-barrel | 1.55e-03 | 27 | 160 | 3 | IPR009000 | |
| Domain | VWC | 1.73e-03 | 28 | 160 | 3 | PF00093 | |
| Domain | ATP_grasp_subdomain_2 | 2.33e-03 | 31 | 160 | 3 | IPR013816 | |
| Domain | Cadherin_2 | 2.34e-03 | 65 | 160 | 4 | PF08266 | |
| Domain | Cadherin_N | 2.34e-03 | 65 | 160 | 4 | IPR013164 | |
| Domain | PENTAXIN | 2.52e-03 | 9 | 160 | 2 | PS00289 | |
| Domain | Biotin_lipoyl | 2.52e-03 | 9 | 160 | 2 | PF00364 | |
| Domain | C1Q | 2.55e-03 | 32 | 160 | 3 | SM00110 | |
| Domain | C1q | 2.55e-03 | 32 | 160 | 3 | PF00386 | |
| Domain | P-loop_NTPase | ABCC3 ABCA13 PFKFB2 RRAS ABCA10 ABCC6 DDX1 EIF2S3 ABCC8 TJP2 RAB40C ABCC12 CHST2 GFM1 ABCG8 AGAP2 | 2.57e-03 | 848 | 160 | 16 | IPR027417 |
| Domain | PH | 2.78e-03 | 278 | 160 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 2.84e-03 | 279 | 160 | 8 | PS50003 | |
| Domain | PH_domain | 2.90e-03 | 280 | 160 | 8 | IPR001849 | |
| Domain | C1q_dom | 3.04e-03 | 34 | 160 | 3 | IPR001073 | |
| Domain | C1Q | 3.04e-03 | 34 | 160 | 3 | PS50871 | |
| Domain | IG_FLMN | 3.14e-03 | 10 | 160 | 2 | SM00557 | |
| Domain | BIOTINYL_LIPOYL | 3.14e-03 | 10 | 160 | 2 | PS50968 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 9.53e-32 | 44 | 133 | 21 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 PLOD1 COL1A1 COL1A2 | 8.66e-29 | 67 | 133 | 22 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 1.79e-28 | 41 | 133 | 19 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL5A3 COL6A5 PLOD1 COL1A1 COL1A2 | 3.20e-26 | 61 | 133 | 20 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 PLOD1 COL1A1 COL1A2 | 1.43e-25 | 90 | 133 | 22 | M631 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL15A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 1.86e-24 | 61 | 133 | 19 | M27103 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL5A3 COL6A5 PLOD1 COL1A1 COL1A2 | 4.99e-24 | 76 | 133 | 20 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 5.35e-24 | 64 | 133 | 19 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL15A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 9.82e-23 | 50 | 133 | 17 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL13A1 COL15A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 3.15e-22 | 53 | 133 | 17 | MM14566 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL1A1 COL1A2 | 1.22e-21 | 46 | 133 | 16 | M198 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 | 5.41e-18 | 20 | 133 | 11 | MM15061 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL1A1 COL1A2 | 6.62e-18 | 74 | 133 | 16 | M160 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL13A1 COL16A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 1.05e-17 | 76 | 133 | 16 | MM14867 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 4.65e-17 | 140 | 133 | 19 | M587 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 COL1A1 COL1A2 | 5.77e-17 | 32 | 133 | 12 | MM14924 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL13A1 COL16A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 7.11e-17 | 85 | 133 | 16 | M16441 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL13A1 COL15A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 4.49e-16 | 114 | 133 | 17 | MM14571 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A3 COL4A4 CACNA1C COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 | 2.61e-15 | 42 | 133 | 12 | M7169 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 9.22e-15 | 76 | 133 | 14 | M27219 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 | 3.36e-14 | 38 | 133 | 11 | MM14969 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 PLOD1 COL1A1 COL1A2 | 6.83e-14 | 300 | 133 | 22 | M610 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 1.02e-13 | 30 | 133 | 10 | M27772 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 COL1A1 COL1A2 | 2.31e-13 | 59 | 133 | 12 | M27218 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL5A3 COL6A5 PLOD1 COL1A1 COL1A2 | 3.69e-13 | 258 | 133 | 20 | MM14572 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A3 COL4A4 CACNA1C COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 | 5.33e-13 | 63 | 133 | 12 | M11187 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL1A1 COL1A2 | 9.60e-13 | 66 | 133 | 12 | M18 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 3.47e-12 | 41 | 133 | 10 | M27778 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.52e-12 | 19 | 133 | 8 | MM15512 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 | 4.42e-12 | 57 | 133 | 11 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 | 5.42e-12 | 58 | 133 | 11 | M2049 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 COL1A1 COL1A2 | 1.53e-11 | 47 | 133 | 10 | MM14925 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL2A1 COL4A4 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL6A6 COL5A3 COL1A1 COL1A2 | 1.91e-11 | 84 | 133 | 12 | M7098 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.50e-10 | 30 | 133 | 8 | MM15517 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.94e-09 | 15 | 133 | 6 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_MET | COL2A1 COL5A1 COL5A2 COL11A1 COL11A2 COL27A1 COL5A3 COL24A1 COL1A1 COL1A2 | 3.29e-09 | 79 | 133 | 10 | M27643 |
| Pathway | KEGG_FOCAL_ADHESION | COL2A1 COL4A4 COL4A6 COL5A1 COL5A2 FLNA COL6A2 FLNC COL11A1 COL11A2 COL6A6 COL5A3 COL1A1 COL1A2 | 5.54e-09 | 199 | 133 | 14 | M7253 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.07e-08 | 18 | 133 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.07e-08 | 18 | 133 | 6 | MM14882 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.63e-07 | 44 | 133 | 7 | M11911 | |
| Pathway | WP_FOCAL_ADHESION | COL2A1 COL4A4 COL4A6 COL5A1 COL5A2 FLNA COL6A2 COL11A1 COL11A2 COL5A3 COL1A1 COL1A2 | 1.98e-07 | 187 | 133 | 12 | MM15913 |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.08e-07 | 67 | 133 | 8 | MM15345 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL6A6 COL27A1 POLR2B HNRNPM COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 5.81e-07 | 532 | 133 | 19 | M27870 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.52e-06 | 10 | 133 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.52e-06 | 10 | 133 | 4 | MM1560 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL6A6 POLR2B COL5A3 COL6A5 COL1A1 COL1A2 | 2.01e-06 | 418 | 133 | 16 | MM15587 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.37e-06 | 11 | 133 | 4 | M15422 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.88e-06 | 43 | 133 | 6 | M53 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.54e-06 | 12 | 133 | 4 | MM1526 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.74e-06 | 27 | 133 | 5 | M27217 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.07e-06 | 13 | 133 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.07e-06 | 13 | 133 | 4 | M12950 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL2A1 COL4A4 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 ACACA COL5A3 PFKFB2 COL1A1 COL1A2 | 5.53e-06 | 302 | 133 | 13 | M39719 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 RRAS | 6.64e-06 | 261 | 133 | 12 | MM15676 |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.04e-06 | 14 | 133 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 7.04e-06 | 14 | 133 | 4 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.54e-06 | 15 | 133 | 4 | MM14922 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL2A1 COL4A4 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 ACACA COL5A3 PFKFB2 COL1A1 COL1A2 | 1.26e-05 | 326 | 133 | 13 | MM15917 |
| Pathway | KEGG_PROPANOATE_METABOLISM | 1.33e-05 | 33 | 133 | 5 | M4086 | |
| Pathway | WP_13Q1212_COPY_NUMBER_VARIATION | 1.55e-05 | 34 | 133 | 5 | M48103 | |
| Pathway | WP_FOCAL_ADHESION | COL2A1 COL4A4 COL4A6 COL5A2 FLNA COL6A2 FLNC COL5A3 COL1A1 COL1A2 | 1.88e-05 | 199 | 133 | 10 | M39402 |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 2.63e-05 | 19 | 133 | 4 | M27221 | |
| Pathway | WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY | 3.26e-05 | 20 | 133 | 4 | M39751 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 3.26e-05 | 20 | 133 | 4 | M15394 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 3.50e-05 | 40 | 133 | 5 | M7934 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 5.00e-05 | 43 | 133 | 5 | M39565 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 5.83e-05 | 23 | 133 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 5.83e-05 | 23 | 133 | 4 | MM1427 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 RPL22 COL4A3 COL4A4 CACNA1C COL4A5 COL5A1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 RRAS RPL5 AGAP2 | 1.02e-04 | 575 | 133 | 16 | M29853 |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.30e-04 | 28 | 133 | 4 | MM15957 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.70e-04 | 12 | 133 | 3 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.70e-04 | 12 | 133 | 3 | M27352 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.72e-04 | 30 | 133 | 4 | M27216 | |
| Pathway | WP_MRNA_PROCESSING | 1.89e-04 | 126 | 133 | 7 | M39406 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 2.82e-04 | 34 | 133 | 4 | M3397 | |
| Pathway | WP_MRNA_PROCESSING | RPL22 COL4A3 SART3 SRSF7 SFSWAP SNRNP35 HNRNPM DDX1 PPM1G SUGP2 SYNJ2 SUGP1 SYNCRIP | 3.37e-04 | 451 | 133 | 13 | MM15946 |
| Pathway | WP_PI3KAKT_SIGNALING | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL9A1 COL6A6 COL6A5 COL1A1 COL1A2 | 3.66e-04 | 339 | 133 | 11 | M39736 |
| Pathway | WP_CHOLESTASIS | 7.12e-04 | 19 | 133 | 3 | M45520 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A3 COL4A4 COL4A5 COL5A1 EPRS1 COL5A2 COL6A2 COL9A1 COL6A6 COL5A3 COL6A5 RRAS | 9.20e-04 | 502 | 133 | 13 | MM14537 |
| Pathway | REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR | 1.29e-03 | 6 | 133 | 2 | M48273 | |
| Pathway | REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR | 1.29e-03 | 6 | 133 | 2 | MM17245 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE | 1.29e-03 | 6 | 133 | 2 | M47785 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 1.80e-03 | 7 | 133 | 2 | M48265 | |
| Pathway | WP_ACETYLCHOLINE_SYNTHESIS | 1.80e-03 | 7 | 133 | 2 | MM15975 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 1.80e-03 | 7 | 133 | 2 | MM14654 | |
| Pathway | WP_ACETYLCHOLINE_SYNTHESIS | 1.80e-03 | 7 | 133 | 2 | M39640 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.82e-03 | 26 | 133 | 3 | MM14793 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 2.26e-03 | 28 | 133 | 3 | M42541 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 2.38e-03 | 8 | 133 | 2 | M48236 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 2.38e-03 | 8 | 133 | 2 | M26991 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 2.38e-03 | 8 | 133 | 2 | M27005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN | 2.38e-03 | 8 | 133 | 2 | M47784 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.44e-03 | 99 | 133 | 5 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.90e-03 | 103 | 133 | 5 | M758 | |
| Pathway | WP_TCA_CYCLE | 3.04e-03 | 31 | 133 | 3 | MM15856 | |
| Pathway | KEGG_CITRATE_CYCLE_TCA_CYCLE | 3.04e-03 | 31 | 133 | 3 | M3985 | |
| Pathway | REACTOME_RECYCLING_OF_EIF2_GDP | 3.05e-03 | 9 | 133 | 2 | MM15418 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 3.05e-03 | 9 | 133 | 2 | M40064 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 3.64e-03 | 33 | 133 | 3 | M39870 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS | 3.78e-03 | 10 | 133 | 2 | MM17234 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 4.21e-21 | 135 | 166 | 18 | 28675934 |
| Pubmed | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 1.79e-20 | 175 | 166 | 19 | 28071719 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL11A2 COL16A1 COL27A1 COL5A3 COL6A5 COL1A1 COL1A2 | 4.34e-20 | 62 | 166 | 14 | 28344315 |
| Pubmed | COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 IL16 COL13A1 COL15A1 COL16A1 COL27A1 COL5A3 COL6A5 COL24A1 PLOD1 COL1A1 COL1A2 | 5.99e-18 | 167 | 166 | 17 | 22159717 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 3.96e-16 | 8 | 166 | 7 | 20059976 | |
| Pubmed | 1.08e-14 | 6 | 166 | 6 | 21467034 | ||
| Pubmed | 1.08e-14 | 6 | 166 | 6 | 10722718 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.08e-14 | 6 | 166 | 6 | 8563024 | |
| Pubmed | COL4A3 COL4A4 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL13A1 COL15A1 COL16A1 COL6A6 COL24A1 COL1A1 COL1A2 | 2.46e-14 | 153 | 166 | 14 | 25037231 | |
| Pubmed | 2.29e-13 | 25 | 166 | 8 | 19180518 | ||
| Pubmed | 8.96e-13 | 9 | 166 | 6 | 9878537 | ||
| Pubmed | COL2A1 COL4A3 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL5A3 COL1A2 | 1.95e-12 | 210 | 166 | 14 | 16537572 | |
| Pubmed | 2.39e-12 | 19 | 166 | 7 | 15689378 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.39e-11 | 6 | 166 | 5 | 17029294 | |
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 17876790 | ||
| Pubmed | RPL22 SART3 HSPE1 BCL9L EPRS1 FLNA SLC4A7 ACACA ACACB PDHA1 DLGAP4 ETFA HNRNPM TRIOBP SUCLA2 CDC42BPB PPM1G PREB SUGP2 MAP3K10 TJP2 MRPS5 GFM1 ALDH5A1 RPL5 AGAP2 | 3.91e-11 | 1139 | 166 | 26 | 36417873 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 5.21e-11 | 15 | 166 | 6 | 9832566 | |
| Pubmed | 1.29e-10 | 8 | 166 | 5 | 1377218 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 1.29e-10 | 8 | 166 | 5 | 33875569 | |
| Pubmed | 1.29e-10 | 8 | 166 | 5 | 18816857 | ||
| Pubmed | 1.29e-10 | 8 | 166 | 5 | 3997552 | ||
| Pubmed | 1.29e-10 | 8 | 166 | 5 | 15872058 | ||
| Pubmed | 1.29e-10 | 8 | 166 | 5 | 10382266 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL22 HSPE1 FLNA FLNC ACACA SRSF7 SFSWAP PDHA1 HNRNPM DDX1 PPM1G NOP14 SUGP2 CTR9 EIF2S3 AHNAK MEPCE SUGP1 MRPS5 GFM1 PLOD1 RPL5 SYNCRIP | 4.10e-10 | 989 | 166 | 23 | 36424410 |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 5.01e-10 | 4 | 166 | 4 | 17683922 | |
| Pubmed | 5.76e-10 | 10 | 166 | 5 | 9415455 | ||
| Pubmed | 6.72e-10 | 39 | 166 | 7 | 33580754 | ||
| Pubmed | SART3 EPRS1 FLNA POLR2B HNRNPM DDX1 NOP14 SUGP2 EIF2S3 MEPCE TJP2 PATJ SYNCRIP | 8.36e-10 | 274 | 166 | 13 | 34244482 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | COL2A1 COL5A1 COL5A2 COL6A2 COL15A1 COL6A6 COL5A3 COL1A1 COL1A2 | 1.03e-09 | 97 | 166 | 9 | 27559042 |
| Pubmed | The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. | 1.05e-09 | 11 | 166 | 5 | 20696843 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.80e-09 | 12 | 166 | 5 | 12180907 | |
| Pubmed | SART3 COL5A1 FLNA FLNC AARS1 ACACA PDHA1 POGZ PPM1G NOP14 SUGP2 WDR6 AHNAK CGN TJP2 PLOD1 RPL5 SYNCRIP | 2.78e-09 | 653 | 166 | 18 | 22586326 | |
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 2.94e-09 | 27 | 166 | 6 | 12192060 | |
| Pubmed | 4.18e-09 | 50 | 166 | 7 | 23658023 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL22 EPRS1 FLNA ACACA ACACB SRSF7 PDHA1 POLR2B ETFA HNRNPM SUCLA2 DDX1 PHF2 NOP14 CTR9 EIF2S3 AHNAK MEPCE TJP2 MRPS5 HSD17B4 PLOD1 RPL5 ZNF687 SYNCRIP | 4.26e-09 | 1318 | 166 | 25 | 30463901 |
| Pubmed | FLNA SRSF7 PDHA1 POLR2B HNRNPM EIF2S3B DDX1 EIF2S3 TJP2 ALDH2 GFM1 | 4.37e-09 | 203 | 166 | 11 | 35012549 | |
| Pubmed | RPL22 SART3 EPRS1 FLNA FLNC IL16 CARMIL2 SELENBP1 SRSF7 PDHA1 DLGAP4 HNRNPM EIF2S3B SUCLA2 CDC42BPB DDX1 SUGP2 EIF2S3 TJP2 ALDH2 PLCH1 PLP1 RPL5 SNTA1 AGAP2 SYNCRIP | 4.88e-09 | 1431 | 166 | 26 | 37142655 | |
| Pubmed | RPL22 EPRS1 FLNA AARS1 SRSF7 POLR2B HNRNPM POGZ SUCLA2 CDC42BPB DDX1 SUGP2 EIF2S3 AHNAK MRPS5 RPL5 SYNCRIP | 5.38e-09 | 601 | 166 | 17 | 33658012 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RPL22 PLIN4 ANKRD35 HSPE1 EPRS1 FLNA COL6A2 FLNC AARS1 SLC4A7 ACACA PDHA1 ETFA HNRNPM SUCLA2 ASH2L DDX1 AHNAK MEPCE MAP3K10 ALDH2 HSD17B4 GFM1 PLOD1 RPL5 SYNCRIP | 6.49e-09 | 1451 | 166 | 26 | 30550785 |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 2426947 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 7.45e-09 | 6 | 166 | 4 | 10534397 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 9101290 | ||
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 15922184 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 7.45e-09 | 6 | 166 | 4 | 19275937 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 7.45e-09 | 6 | 166 | 4 | 9506531 | |
| Pubmed | Retarded skeletal development in transgenic mice with a type II collagen mutation. | 7.45e-09 | 6 | 166 | 4 | 8952549 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 7.45e-09 | 6 | 166 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 7.45e-09 | 6 | 166 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 7.45e-09 | 6 | 166 | 4 | 6389236 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 12225806 | ||
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 20301479 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 7.45e-09 | 6 | 166 | 4 | 9673377 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 11732842 | ||
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 7.45e-09 | 6 | 166 | 4 | 22492985 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 8.79e-09 | 86 | 166 | 8 | 28327460 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL22 HSPE1 FLNC NPTX1 NPTX2 SRSF7 SFSWAP POLR2B HNRNPM TRIOBP POGZ CHMP2A AHDC1 DDX1 PHF2 NOP14 SUGP2 SUGP1 HSD17B4 PLOD1 RPL5 SYNCRIP | 1.17e-08 | 1082 | 166 | 22 | 38697112 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | COL2A1 RPL22 COL4A3 EPRS1 FLNA FLNC AARS1 COL13A1 ACACA SELENBP1 ETFA HNRNPM COL5A3 NHLRC2 DDX1 EIF2S3 AHNAK RPL5 SYNCRIP | 1.26e-08 | 807 | 166 | 19 | 30575818 |
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 1.38e-08 | 17 | 166 | 5 | 10213384 | |
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.73e-08 | 7 | 166 | 4 | 8006028 | |
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 10416788 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 11711546 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 1724753 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL22 SART3 HSPE1 EPRS1 FLNA AARS1 ACACA SRSF7 PDHA1 POLR2B ETFA HNRNPM POGZ SUCLA2 DDX1 PHF2 WDR6 CTR9 EIF2S3 ALDH2 CHST2 HSD17B4 GFM1 RPL5 SYNCRIP | 1.99e-08 | 1425 | 166 | 25 | 30948266 |
| Pubmed | RPL22 SART3 CACNA1C HSPE1 EPRS1 FLNA FLNC ACACB PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1 GRK6 HNRNPM DDX1 NRXN3 NOP14 CTR9 AHNAK ALDH2 PLCH1 HSD17B4 TNNT1 AGAP2 SYNCRIP | 2.50e-08 | 1442 | 166 | 25 | 35575683 | |
| Pubmed | RPL22 ANKRD35 HSPE1 EPRS1 FLNA ACACA SELENBP1 SRSF7 PDHA1 PDHA2 POLR2B ETFA HNRNPM AHDC1 DDX1 MED4 EIF2S3 CGN MEPCE DOT1L PATJ RPL5 SYNCRIP | 3.16e-08 | 1247 | 166 | 23 | 27684187 | |
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 3.45e-08 | 8 | 166 | 4 | 17510210 | |
| Pubmed | Type XIII collagen strongly affects bone formation in transgenic mice. | 3.45e-08 | 8 | 166 | 4 | 16007336 | |
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 9164858 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 3.45e-08 | 8 | 166 | 4 | 10970885 | |
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 29422532 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 3.45e-08 | 8 | 166 | 4 | 24563484 | |
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 3.45e-08 | 8 | 166 | 4 | 11867580 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AARS1 SLC4A7 CARMIL2 ACACA PARD3B PFKFB2 DDX1 KSR1 SYNJ2 AHNAK CGN MEPCE MAP3K10 TJP2 TMEM102 BRD1 PLCH1 PATJ RGL2 | 3.51e-08 | 861 | 166 | 19 | 36931259 |
| Pubmed | RPL22 EPRS1 FLNA AARS1 ACACA PDHA1 HNRNPM SUCLA2 HIBCH EIF2S3 ALDH2 HSD17B4 GFM1 ALDH5A1 RPL5 | 4.88e-08 | 534 | 166 | 15 | 35032548 | |
| Pubmed | 6.19e-08 | 9 | 166 | 4 | 12101409 | ||
| Pubmed | 6.19e-08 | 9 | 166 | 4 | 8900172 | ||
| Pubmed | RPL22 HSPE1 EPRS1 FLNA FLNC AARS1 SRSF7 PDHA1 HNRNPM CDC42BPB DDX1 EIF2S3 AHNAK MRPS5 HSD17B4 ALDH5A1 RPL5 SYNCRIP | 7.29e-08 | 809 | 166 | 18 | 32129710 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RPL22 EPRS1 FLNA FLNC ACACA SRSF7 HNRNPM COL5A3 SUGP2 AHNAK CGN RPL5 SYNCRIP COL1A1 | 8.15e-08 | 477 | 166 | 14 | 31300519 |
| Pubmed | 9.21e-08 | 24 | 166 | 5 | 25344368 | ||
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 2446864 | ||
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 9136074 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.03e-07 | 10 | 166 | 4 | 15345741 | |
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 14559231 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 1.07e-07 | 3 | 166 | 3 | 27576055 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 23546968 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 37158802 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 24522496 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 7962065 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 28704582 | ||
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 1.07e-07 | 3 | 166 | 3 | 1571108 | |
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 1.07e-07 | 3 | 166 | 3 | 30647093 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 36130833 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 1.07e-07 | 3 | 166 | 3 | 38433557 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 15908193 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 1.07e-07 | 3 | 166 | 3 | 27377778 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 15141750 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 1.07e-07 | 3 | 166 | 3 | 9582436 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 1.07e-07 | 3 | 166 | 3 | 2010058 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 14633121 | ||
| Interaction | COLGALT2 interactions | COL2A1 COL4A5 COL6A2 COL13A1 COL16A1 C1QTNF9B COLEC11 C1QTNF9 C1QTNF1 COL1A1 | 1.42e-10 | 67 | 162 | 10 | int:COLGALT2 |
| Interaction | DCN interactions | 1.67e-09 | 43 | 162 | 8 | int:DCN | |
| Interaction | PLOD1 interactions | COL2A1 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL13A1 COL16A1 DLGAP4 NHLRC2 DDX1 AHNAK TJP2 C1QTNF1 PLOD1 COL1A1 | 1.88e-09 | 292 | 162 | 16 | int:PLOD1 |
| Interaction | MMP9 interactions | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL1A1 COL1A2 | 3.22e-09 | 67 | 162 | 9 | int:MMP9 |
| Interaction | LAIR2 interactions | 5.00e-09 | 49 | 162 | 8 | int:LAIR2 | |
| Interaction | FN1 interactions | COL2A1 RPL22 COL4A3 COL4A4 COL4A5 HSPE1 COL4A6 EPRS1 FLNA COL6A2 FLNC AARS1 COL9A1 COL13A1 ACACA HNRNPM DDX1 CTR9 EIF2S3 AHNAK C1QTNF1 RPL5 SYNCRIP COL1A1 COL1A2 | 1.86e-08 | 848 | 162 | 25 | int:FN1 |
| Interaction | PLOD3 interactions | RPL22 COL4A6 COL6A2 COL13A1 COL16A1 C1QTNF9B DDX1 COLEC11 AHNAK C1QTNF1 PLOD1 MARCO | 3.01e-08 | 183 | 162 | 12 | int:PLOD3 |
| Interaction | COL2A1 interactions | COL2A1 COL9A1 COL11A1 COL16A1 C1QTNF9B C1QTNF9 C1QTNF1 PLOD1 | 4.43e-08 | 64 | 162 | 8 | int:COL2A1 |
| Interaction | COL6A2 interactions | COL6A2 COL9A1 COL11A1 COL16A1 C1QTNF9B COLEC11 C1QTNF9 C1QTNF1 PLOD1 | 4.54e-08 | 90 | 162 | 9 | int:COL6A2 |
| Interaction | COL5A1 interactions | 5.01e-08 | 65 | 162 | 8 | int:COL5A1 | |
| Interaction | COL16A1 interactions | 2.48e-07 | 18 | 162 | 5 | int:COL16A1 | |
| Interaction | OSM interactions | 4.44e-07 | 20 | 162 | 5 | int:OSM | |
| Interaction | TGFBI interactions | 1.47e-06 | 25 | 162 | 5 | int:TGFBI | |
| Interaction | CD93 interactions | 1.55e-06 | 45 | 162 | 6 | int:CD93 | |
| Interaction | CHMP4B interactions | RPL22 COL5A1 EPRS1 COL5A2 FLNA FLNC SLC4A7 ACACA SRSF7 ETFA HNRNPM CHMP2A AHNAK TJP2 PLOD1 RPL5 HSPA7 SYNCRIP PDZD2 COL1A2 | 1.64e-06 | 727 | 162 | 20 | int:CHMP4B |
| Interaction | USP53 interactions | 1.77e-06 | 138 | 162 | 9 | int:USP53 | |
| Interaction | C1QTNF1 interactions | 2.01e-06 | 47 | 162 | 6 | int:C1QTNF1 | |
| Interaction | GLDC interactions | SART3 EPRS1 FLNA POLR2B HNRNPM DDX1 NOP14 SUGP2 EIF2S3 MEPCE TJP2 PATJ SYNCRIP | 2.06e-06 | 321 | 162 | 13 | int:GLDC |
| Interaction | NPTXR interactions | 2.21e-06 | 27 | 162 | 5 | int:NPTXR | |
| Interaction | COL4A2 interactions | 2.39e-06 | 75 | 162 | 7 | int:COL4A2 | |
| Interaction | MAG interactions | 3.21e-06 | 29 | 162 | 5 | int:MAG | |
| Interaction | MIR143 interactions | 3.70e-06 | 80 | 162 | 7 | int:MIR143 | |
| Interaction | COL6A1 interactions | COL2A1 COL9A1 C1QTNF9B COLEC11 C1QTNF9 C1QTNF1 HSD17B4 PLOD1 | 4.76e-06 | 117 | 162 | 8 | int:COL6A1 |
| Interaction | TARDBP interactions | RPL22 SRSF7 PDHA1 HNRNPM NHLRC2 CHMP2A DDX1 NOP14 DBF4 EIF2S3 AHNAK ALDH2 DOT1L PLP1 RPL5 SYNCRIP | 4.80e-06 | 520 | 162 | 16 | int:TARDBP |
| Interaction | MMP2 interactions | 6.49e-06 | 87 | 162 | 7 | int:MMP2 | |
| Interaction | MIR221 interactions | 8.13e-06 | 90 | 162 | 7 | int:MIR221 | |
| Interaction | MIR1-1 interactions | 8.13e-06 | 90 | 162 | 7 | int:MIR1-1 | |
| Interaction | ECT2 interactions | RPL22 COL5A1 EPRS1 COL5A2 FLNA FLNC SRSF7 ABCA13 ETFA HNRNPM PPM1G WDR6 AHNAK TJP2 HSD17B4 GFM1 PLOD1 RPL5 HSPA7 SYNCRIP PDZD2 | 9.18e-06 | 887 | 162 | 21 | int:ECT2 |
| Interaction | MIRLET7F1 interactions | 1.08e-05 | 94 | 162 | 7 | int:MIRLET7F1 | |
| Interaction | HABP2 interactions | 1.13e-05 | 18 | 162 | 4 | int:HABP2 | |
| Interaction | MIRLET7C interactions | 1.33e-05 | 97 | 162 | 7 | int:MIRLET7C | |
| Interaction | FBXW7 interactions | RPL22 SART3 EPRS1 FLNA AARS1 SRSF7 POLR2B HNRNPM POGZ SUCLA2 CDC42BPB ASH2L DDX1 KMT2D MED4 SUGP2 EIF2S3 AHNAK TJP2 MRPS5 TAF13 RPL5 NOTCH4 SYNCRIP COL1A2 | 1.37e-05 | 1215 | 162 | 25 | int:FBXW7 |
| Interaction | SPARC interactions | 1.37e-05 | 65 | 162 | 6 | int:SPARC | |
| Interaction | MIR128-2 interactions | 1.53e-05 | 99 | 162 | 7 | int:MIR128-2 | |
| Interaction | H3-4 interactions | EPRS1 PDHA1 POGZ AHDC1 ASH2L PPM1G PHF2 CBX6 AHNAK GATAD1 DOT1L BRD1 TAF13 HSPA7 | 1.63e-05 | 448 | 162 | 14 | int:H3-4 |
| Interaction | MIRLET7D interactions | 1.74e-05 | 101 | 162 | 7 | int:MIRLET7D | |
| Interaction | COL8A2 interactions | 2.11e-05 | 42 | 162 | 5 | int:COL8A2 | |
| Interaction | CIAO1 interactions | RPL22 FLNA SLC4A7 ACACB GRK6 GPATCH1 POLR2B PREB CTR9 MEPCE BRD1 | 2.29e-05 | 289 | 162 | 11 | int:CIAO1 |
| Interaction | MIRLET7E interactions | 2.38e-05 | 106 | 162 | 7 | int:MIRLET7E | |
| Interaction | SOX2 interactions | SART3 HSPE1 BCL9L EPRS1 FLNA COL11A1 COL13A1 MNX1 HNRNPM ING5 TRIOBP EIF2S3B POGZ AHDC1 ASH2L DDX1 KMT2D HIBCH SUGP2 DMKN CTR9 MEPCE MRPS5 ALDH2 PLCH1 RPL5 ZNF687 | 2.50e-05 | 1422 | 162 | 27 | int:SOX2 |
| Interaction | MIR18A interactions | 2.68e-05 | 73 | 162 | 6 | int:MIR18A | |
| Interaction | MIR29B1 interactions | 2.68e-05 | 73 | 162 | 6 | int:MIR29B1 | |
| Interaction | MIR20A interactions | 2.90e-05 | 74 | 162 | 6 | int:MIR20A | |
| Interaction | LARP7 interactions | RPL22 SART3 HSPE1 EPRS1 FLNA ACACA SRSF7 HNRNPM RRAS PPM1G PHF2 MED4 CBX6 CTR9 MEPCE MRPS5 DOT1L PLOD1 PRDM15 RPL5 HSPA7 PURG SYNCRIP | 2.95e-05 | 1113 | 162 | 23 | int:LARP7 |
| Interaction | MIR34B interactions | 3.03e-05 | 110 | 162 | 7 | int:MIR34B | |
| Interaction | SIRT7 interactions | SART3 COL5A1 FLNA FLNC AARS1 ACACA PDHA1 POGZ PPM1G NOP14 SUGP2 WDR6 AHNAK CGN TJP2 PLOD1 RPL5 SYNCRIP | 3.16e-05 | 744 | 162 | 18 | int:SIRT7 |
| Interaction | CFD interactions | RPL22 PLIN4 ANKRD35 HSPE1 EPRS1 FLNA COL6A2 FLNC AARS1 SLC4A7 ACACA PDHA1 ETFA HNRNPM SUCLA2 ASH2L DDX1 AHNAK MEPCE MAP3K10 ALDH2 HSD17B4 GFM1 PLOD1 RPL5 SYNCRIP | 3.21e-05 | 1360 | 162 | 26 | int:CFD |
| Interaction | MIR7-3 interactions | 3.38e-05 | 76 | 162 | 6 | int:MIR7-3 | |
| Interaction | MIR222 interactions | 4.21e-05 | 79 | 162 | 6 | int:MIR222 | |
| Interaction | MIR206 interactions | 4.21e-05 | 79 | 162 | 6 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 4.21e-05 | 79 | 162 | 6 | int:MIR1-2 | |
| Interaction | MIRLET7G interactions | 4.50e-05 | 117 | 162 | 7 | int:MIRLET7G | |
| Interaction | H2BC21 interactions | SART3 EPRS1 POLR2B ING5 POGZ ASH2L PPM1G PHF2 CBX6 CTR9 AHNAK MEPCE GATAD1 TPPP3 BRD1 HSPA7 ZNF687 | 4.72e-05 | 696 | 162 | 17 | int:H2BC21 |
| Interaction | COL12A1 interactions | 4.99e-05 | 50 | 162 | 5 | int:COL12A1 | |
| Interaction | NR2C2 interactions | RPL22 EPRS1 FLNA ACACA ACACB SRSF7 PDHA1 POLR2B ETFA HNRNPM SUCLA2 DDX1 PHF2 NOP14 CTR9 EIF2S3 AHNAK MEPCE TJP2 MRPS5 DOT1L HSD17B4 PLOD1 RPL5 ZNF687 SYNCRIP | 5.41e-05 | 1403 | 162 | 26 | int:NR2C2 |
| Interaction | JADE3 interactions | 5.50e-05 | 51 | 162 | 5 | int:JADE3 | |
| Interaction | COL5A3 interactions | 5.87e-05 | 10 | 162 | 3 | int:COL5A3 | |
| Interaction | KCNJ15 interactions | 5.87e-05 | 10 | 162 | 3 | int:KCNJ15 | |
| Interaction | MIR7-2 interactions | 5.96e-05 | 84 | 162 | 6 | int:MIR7-2 | |
| Interaction | AGR2 interactions | COL2A1 RPL22 COL4A3 EPRS1 FLNA FLNC AARS1 COL13A1 ACACA SELENBP1 ETFA HNRNPM COL5A3 POGZ NHLRC2 DDX1 EIF2S3 AHNAK RPL5 SYNCRIP | 6.28e-05 | 934 | 162 | 20 | int:AGR2 |
| Interaction | MIR18B interactions | 6.37e-05 | 85 | 162 | 6 | int:MIR18B | |
| Interaction | MIR17 interactions | 6.37e-05 | 85 | 162 | 6 | int:MIR17 | |
| Interaction | MIR9-1 interactions | 6.37e-05 | 85 | 162 | 6 | int:MIR9-1 | |
| Interaction | GRWD1 interactions | RPL22 EPRS1 FLNA ACACB POLR2B HNRNPM DDX1 PPM1G KMT2D MEPCE DOT1L RPL5 | 7.73e-05 | 390 | 162 | 12 | int:GRWD1 |
| Interaction | MIR141 interactions | 7.74e-05 | 88 | 162 | 6 | int:MIR141 | |
| Interaction | MEN1 interactions | SART3 COL5A1 EPRS1 SRSF7 GPATCH1 POLR2B HNRNPM POGZ AHDC1 ASH2L DDX1 KMT2D NOP14 SUGP2 DBF4 MEPCE TJP2 DOT1L HSD17B4 RPL5 ZNF687 | 8.07e-05 | 1029 | 162 | 21 | int:MEN1 |
| Interaction | COL11A1 interactions | 8.17e-05 | 29 | 162 | 4 | int:COL11A1 | |
| Interaction | ANTXR2 interactions | 8.17e-05 | 29 | 162 | 4 | int:ANTXR2 | |
| Interaction | TIMP2 interactions | COL2A1 RPL22 COL5A1 COL5A2 FLNA COL16A1 SRSF7 PHF2 COL1A1 COL1A2 | 8.45e-05 | 277 | 162 | 10 | int:TIMP2 |
| Interaction | SERPINE2 interactions | 8.66e-05 | 56 | 162 | 5 | int:SERPINE2 | |
| Interaction | COL14A1 interactions | 8.77e-05 | 90 | 162 | 6 | int:COL14A1 | |
| Interaction | CIT interactions | RPL22 ANKRD35 FLNA FLNC AARS1 SRSF7 PDHA1 POLR2B ETFA HNRNPM EIF2S3B POGZ DDX1 PHF2 NOP14 SUGP2 CTR9 AHNAK MEPCE TJP2 PATJ PLOD1 RPL5 HSPA7 ZNF687 SYNCRIP | 9.31e-05 | 1450 | 162 | 26 | int:CIT |
| Interaction | MIR200C interactions | 9.33e-05 | 91 | 162 | 6 | int:MIR200C | |
| Interaction | RBM39 interactions | RPL22 EPRS1 FLNA AARS1 ACACA SRSF7 GPATCH1 POLR2B ETFA HNRNPM DDX1 SUGP2 EIF2S3 MEPCE SUGP1 NINL TJP2 DOT1L HSD17B4 RPL5 SYNCRIP | 9.62e-05 | 1042 | 162 | 21 | int:RBM39 |
| Interaction | LARP1 interactions | SART3 SRSF7 HNRNPM DDX1 KSR1 CBX6 EIF2S3 CGN MEPCE DOT1L TNNT1 RPL5 PURG | 1.02e-04 | 465 | 162 | 13 | int:LARP1 |
| Interaction | MIR214 interactions | 1.05e-04 | 93 | 162 | 6 | int:MIR214 | |
| Interaction | KIF20A interactions | RPL22 ANKRD35 FLNA FLNC SRSF7 SFSWAP PDHA1 APC2 ETFA HNRNPM CDC42BPB DDX1 SUGP2 WDR6 AHNAK CGN TJP2 HSD17B4 RPL5 HSPA7 SYNCRIP | 1.10e-04 | 1052 | 162 | 21 | int:KIF20A |
| Interaction | MIR19B2 interactions | 1.12e-04 | 94 | 162 | 6 | int:MIR19B2 | |
| Interaction | FNDC5 interactions | RPL22 PLIN4 ANKRD35 HSPE1 EPRS1 FLNA COL6A2 FLNC AARS1 SLC4A7 ACACA PDHA1 ETFA HNRNPM SUCLA2 ASH2L DDX1 AHNAK MEPCE MAP3K10 ALDH2 HSD17B4 GFM1 PLOD1 RPL5 SYNCRIP | 1.16e-04 | 1470 | 162 | 26 | int:FNDC5 |
| Interaction | PDGFA interactions | 1.21e-04 | 32 | 162 | 4 | int:PDGFA | |
| Interaction | MIRLET7A2 interactions | 1.26e-04 | 96 | 162 | 6 | int:MIRLET7A2 | |
| Interaction | POLR1E interactions | POLR2B POGZ PPM1G PHF2 MED4 NOP14 WDR6 CTR9 DOT1L RPL5 ZNF687 | 1.28e-04 | 350 | 162 | 11 | int:POLR1E |
| Interaction | MIRLET7F2 interactions | 1.33e-04 | 97 | 162 | 6 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 1.33e-04 | 97 | 162 | 6 | int:MIR363 | |
| Interaction | SNRPD2 interactions | RPL22 SART3 FLNA SRSF7 SNRNP35 PARD3B NHLRC2 ABCC6 MEPCE SUGP1 DOT1L SYNCRIP | 1.36e-04 | 414 | 162 | 12 | int:SNRPD2 |
| Interaction | COL9A1 interactions | 1.37e-04 | 13 | 162 | 3 | int:COL9A1 | |
| Interaction | MIR19A interactions | 1.57e-04 | 100 | 162 | 6 | int:MIR19A | |
| Interaction | NRAS interactions | SLC4A7 COL16A1 CARMIL2 GRK6 DLGAP4 ETFA CDC42BPB PREB STX18 WDR6 CSNK1G3 EIF2S3 PLCH1 HSD17B4 RGL2 PLP1 | 1.68e-04 | 699 | 162 | 16 | int:NRAS |
| Interaction | BIRC3 interactions | RPL22 SART3 HSPE1 EPRS1 FLNA AARS1 SRSF7 PDHA1 POLR2B ETFA HNRNPM POGZ SUCLA2 DDX1 PHF2 WDR6 CTR9 EIF2S3 ALDH2 CHST2 HSD17B4 GFM1 RPL5 SYNCRIP | 1.70e-04 | 1334 | 162 | 24 | int:BIRC3 |
| Interaction | MIRLET7A3 interactions | 1.75e-04 | 102 | 162 | 6 | int:MIRLET7A3 | |
| Interaction | ARL4D interactions | 1.81e-04 | 146 | 162 | 7 | int:ARL4D | |
| Interaction | RIOK1 interactions | RPL22 SART3 EPRS1 FLNA SRSF7 PDHA1 HNRNPM DDX1 MED4 WDR6 EIF2S3 MRPS5 RPL5 SYNCRIP | 1.84e-04 | 562 | 162 | 14 | int:RIOK1 |
| Interaction | MIR15B interactions | 1.85e-04 | 103 | 162 | 6 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 1.85e-04 | 103 | 162 | 6 | int:MIR7-1 | |
| Interaction | ADGRB1 interactions | 1.94e-04 | 36 | 162 | 4 | int:ADGRB1 | |
| Interaction | MIR19B1 interactions | 1.95e-04 | 104 | 162 | 6 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 1.95e-04 | 104 | 162 | 6 | int:MIR34A | |
| Interaction | RPL26L1 interactions | RPL22 SART3 HNRNPM DDX1 CBX6 EIF2S3 MEPCE DOT1L BRD1 RPL5 PURG SYNCRIP | 1.97e-04 | 431 | 162 | 12 | int:RPL26L1 |
| Interaction | ETFB interactions | 2.14e-04 | 253 | 162 | 9 | int:ETFB | |
| Interaction | C1QTNF9 interactions | 2.16e-04 | 37 | 162 | 4 | int:C1QTNF9 | |
| Cytoband | Xq22 | 1.15e-06 | 22 | 166 | 4 | Xq22 | |
| GeneFamily | Collagens | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 1.45e-34 | 46 | 119 | 21 | 490 |
| GeneFamily | PDZ domain containing | 7.28e-07 | 152 | 119 | 9 | 1220 | |
| GeneFamily | ATP binding cassette subfamily C | 1.22e-06 | 13 | 119 | 4 | 807 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 2.11e-04 | 18 | 119 | 3 | 1372 | |
| GeneFamily | PHD finger proteins | 3.19e-04 | 90 | 119 | 5 | 88 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 3.91e-04 | 22 | 119 | 3 | 579 | |
| GeneFamily | Collagens|Collagen proteoglycans | 4.24e-04 | 5 | 119 | 2 | 575 | |
| GeneFamily | Long pentraxins | 4.24e-04 | 5 | 119 | 2 | 1142 | |
| GeneFamily | Clustered protocadherins | 8.36e-04 | 64 | 119 | 4 | 20 | |
| GeneFamily | ATP binding cassette subfamily A | 3.71e-03 | 14 | 119 | 2 | 805 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 6.83e-03 | 19 | 119 | 2 | 132 | |
| GeneFamily | Aldehyde dehydrogenases | 6.83e-03 | 19 | 119 | 2 | 398 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 6.83e-03 | 19 | 119 | 2 | 832 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 1.31e-35 | 43 | 164 | 21 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 2.50e-35 | 44 | 164 | 21 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 3.83e-17 | 270 | 164 | 21 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 5.56e-17 | 275 | 164 | 21 | M5884 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 IL16 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 C1QTNF9B COL5A3 COL6A5 EGFL6 COLEC11 COL24A1 FCN2 C1QTNF9 C1QTNF1 PLOD1 COL1A1 COL1A2 | 6.00e-12 | 1008 | 164 | 29 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL6A2 COL9A1 IL16 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL27A1 C1QTNF9B COL5A3 COL6A5 EGFL6 COLEC11 COL24A1 FCN2 C1QTNF9 C1QTNF1 PLOD1 COL1A1 COL1A2 | 9.20e-12 | 1026 | 164 | 29 | M5889 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.28e-10 | 40 | 164 | 8 | M5887 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.59e-10 | 29 | 164 | 7 | MM17055 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | ANKRD35 COL4A6 COL5A1 ABCC3 FLNA FLNC COL9A1 COL13A1 COL16A1 ACACB COL27A1 TUB KSR1 DMKN C1QTNF1 ALDH2 CHST2 COL1A2 | 2.23e-09 | 493 | 164 | 18 | M19391 |
| Coexpression | GU_PDEF_TARGETS_UP | 1.51e-08 | 71 | 164 | 8 | M3955 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A5 COL4A6 COL5A1 COL5A2 FLNA COL6A2 COL13A1 COL15A1 RUNDC3B COL27A1 COL5A3 MCTP1 CBX6 NOTCH4 ZNF687 COL1A1 COL1A2 | 2.10e-08 | 505 | 164 | 17 | M39167 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | COL5A1 COL5A2 FLNA COL6A2 COL11A1 COL16A1 COL5A3 PLOD1 SNTB1 COL1A1 COL1A2 | 5.76e-08 | 200 | 164 | 11 | M5930 |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.22e-07 | 62 | 164 | 7 | M16774 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.69e-07 | 65 | 164 | 7 | M39309 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 5.06e-07 | 111 | 164 | 8 | M45685 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 7.57e-07 | 117 | 164 | 8 | M39300 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.72e-06 | 91 | 164 | 7 | M40180 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 3.04e-06 | 64 | 164 | 6 | M2572 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 4.01e-06 | 146 | 164 | 8 | M40222 | |
| Coexpression | MANALO_HYPOXIA_UP | 6.11e-06 | 205 | 164 | 9 | M259 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL5A1 EPRS1 COL5A2 FLNA COL6A2 SLC4A7 COL15A1 COL16A1 COL5A3 SYNJ2 EIF2S3 AHNAK PLOD1 SYNCRIP COL1A1 COL1A2 | 6.32e-06 | 681 | 164 | 16 | M39175 |
| Coexpression | PILON_KLF1_TARGETS_UP | COL2A1 ABCC3 COL5A2 COL6A2 COL11A1 HIBCH SUGP2 FCN2 ABCC8 CGN MARCO SNTB1 COL1A1 COL1A2 | 8.40e-06 | 541 | 164 | 14 | MM1061 |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 9.90e-06 | 22 | 164 | 4 | M40074 | |
| Coexpression | PILON_KLF1_TARGETS_UP | COL2A1 ABCC3 COL5A2 COL6A2 COL11A1 HIBCH SUGP2 ABCC8 CGN MARCO SNTB1 COL1A1 COL1A2 | 1.81e-05 | 503 | 164 | 13 | M2226 |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 2.57e-05 | 137 | 164 | 7 | M40313 | |
| Coexpression | KIM_MYCN_AMPLIFICATION_TARGETS_UP | 2.66e-05 | 93 | 164 | 6 | M18532 | |
| Coexpression | HATADA_METHYLATED_IN_LUNG_CANCER_UP | COL2A1 CACNA1C COL5A1 IL16 PCDHGB2 AOX1 MEPCE C1QTNF1 TPPP3 COL1A1 COL1A2 | 2.72e-05 | 377 | 164 | 11 | M19508 |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | COL4A5 COL4A6 ABCC3 SLC4A7 ACACA SELENBP1 ACACB AOX1 ABCC6 SLC7A8 ABCC8 AHNAK TPPP3 PATJ TNNT1 | 3.56e-05 | 699 | 164 | 15 | M4960 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 3.79e-05 | 99 | 164 | 6 | M39152 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN | 3.81e-05 | 199 | 164 | 8 | M4997 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 3.82e-05 | 11 | 164 | 3 | M47997 | |
| Coexpression | GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP | 3.95e-05 | 200 | 164 | 8 | M4541 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | BCL9L COL5A2 AARS1 COL11A1 ABCA13 KMT2D DMKN WDR6 CTR9 AHNAK PATJ ALDH5A1 COL1A1 | 4.38e-05 | 548 | 164 | 13 | M16859 |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 5.92e-05 | 34 | 164 | 4 | M1955 | |
| Coexpression | DESCARTES_FETAL_HEART_STROMAL_CELLS | 5.92e-05 | 34 | 164 | 4 | M40199 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 6.65e-05 | 35 | 164 | 4 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.65e-05 | 35 | 164 | 4 | M11788 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 6.84e-05 | 68 | 164 | 5 | M45669 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.34e-05 | 69 | 164 | 5 | M10165 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL2A1 FOXD2 PCSK2 ANKRD35 COL4A5 COL4A6 ABCC3 NPTX1 MNX1 COL27A1 PARD3B EGFL6 COL24A1 ABCC8 TPPP3 PLP1 SNTB1 AGAP2 PDZD2 | 7.44e-05 | 1115 | 164 | 19 | M10371 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 7.44e-05 | 36 | 164 | 4 | MM1212 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 7.44e-05 | 36 | 164 | 4 | MM833 | |
| Coexpression | MA_RAT_AGING_DN | 1.01e-04 | 170 | 164 | 7 | MM16097 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 1.02e-04 | 229 | 164 | 8 | MM16607 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.03e-04 | 74 | 164 | 5 | M13547 | |
| Coexpression | ZHU_CMV_ALL_DN | 1.06e-04 | 119 | 164 | 6 | M14555 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | COL5A1 COL5A2 COL6A2 FLNC COL15A1 COL16A1 ETFA COL5A3 COL1A1 COL1A2 | 1.17e-04 | 369 | 164 | 10 | MM16610 |
| Coexpression | DELYS_THYROID_CANCER_UP | PCSK2 ABCC3 COL5A2 NPTX2 COL11A1 COL13A1 RRAS ABCC6 CHST2 MARCO COL1A1 | 1.20e-04 | 445 | 164 | 11 | M3645 |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN | 1.24e-04 | 77 | 164 | 5 | M17937 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 1.39e-04 | 125 | 164 | 6 | M1969 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.40e-04 | 79 | 164 | 5 | M18400 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.45e-04 | 126 | 164 | 6 | M39132 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.49e-04 | 80 | 164 | 5 | MM1285 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | COL4A5 COL5A1 COL5A2 FLNA COL6A2 COL27A1 EGFL6 AHNAK COL1A1 COL1A2 | 1.65e-04 | 385 | 164 | 10 | M39264 |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | COL4A3 COL4A4 PCSK2 AOX1 COLEC11 HIBCH WDR6 AHNAK MEPCE C1QTNF1 PLP1 RPL5 | 1.77e-04 | 546 | 164 | 12 | M3837 |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 1.78e-04 | 316 | 164 | 9 | M2293 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.83e-04 | 18 | 164 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.83e-04 | 18 | 164 | 3 | M13796 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | HSPE1 COL5A1 COL6A2 COL15A1 COLEC11 CTR9 PLOD1 COL1A1 COL1A2 | 1.86e-04 | 318 | 164 | 9 | M41707 |
| Coexpression | ZHU_CMV_24_HR_DN | 1.87e-04 | 84 | 164 | 5 | M4065 | |
| Coexpression | PEREZ_TP53_TARGETS | COL2A1 PLIN4 COL4A4 COL5A2 FLNC COL13A1 COL15A1 MCHR1 ABCA13 COL27A1 APC2 TUB AHDC1 KSR1 SHE C1QTNF1 ABCC12 CHST2 BRD1 | 1.94e-04 | 1201 | 164 | 19 | M4391 |
| Coexpression | JONES_OVARY_THECA | 1.96e-04 | 46 | 164 | 4 | M48349 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 2.09e-04 | 323 | 164 | 9 | MM1066 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.14e-04 | 47 | 164 | 4 | M7585 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 2.16e-04 | 19 | 164 | 3 | M15125 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 2.24e-04 | 257 | 164 | 8 | M13867 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.28e-04 | 194 | 164 | 7 | M39122 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN | 2.43e-04 | 196 | 164 | 7 | M6174 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.49e-04 | 261 | 164 | 8 | M1834 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | COL5A1 COL5A2 FLNA COL6A2 NPTX1 COL15A1 TRIOBP NRXN3 AHNAK TJP2 COL1A1 COL1A2 | 2.49e-04 | 567 | 164 | 12 | M2129 |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP | 2.51e-04 | 197 | 164 | 7 | M8414 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP | 2.58e-04 | 198 | 164 | 7 | M9924 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN | 2.67e-04 | 199 | 164 | 7 | M3738 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_DN | 2.67e-04 | 199 | 164 | 7 | M4467 | |
| Coexpression | GSE27786_NKCELL_VS_MONO_MAC_DN | 2.75e-04 | 200 | 164 | 7 | M4863 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 2.75e-04 | 200 | 164 | 7 | M3575 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN | 2.75e-04 | 200 | 164 | 7 | M6430 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP | 2.75e-04 | 200 | 164 | 7 | M5003 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN | 2.75e-04 | 200 | 164 | 7 | M5212 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP | 2.75e-04 | 200 | 164 | 7 | M7808 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ATPSCKMT PLIN4 CACNA1C COL4A5 COL5A1 COL5A2 NPTX1 COL11A1 COL11A2 SLC4A7 PREB STX18 CSNK1G3 AHNAK TJP2 ABCG8 COL1A1 COL1A2 | 2.83e-04 | 1136 | 164 | 18 | M2247 |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | COL5A1 COL5A2 COL6A2 COL15A1 AHNAK TPPP3 PLOD1 COL1A1 COL1A2 | 2.86e-04 | 337 | 164 | 9 | MM16606 |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 2.94e-04 | 21 | 164 | 3 | MM1196 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.98e-04 | 268 | 164 | 8 | M45796 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 3.01e-04 | 93 | 164 | 5 | M4752 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 3.39e-04 | 22 | 164 | 3 | M1627 | |
| Coexpression | SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 | 3.42e-04 | 422 | 164 | 10 | M4308 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 3.69e-04 | 210 | 164 | 7 | M2010 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 3.84e-04 | 5 | 164 | 2 | M47996 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 3.88e-04 | 23 | 164 | 3 | M48001 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 3.93e-04 | 55 | 164 | 4 | MM3666 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 4.38e-04 | 284 | 164 | 8 | M2885 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 4.49e-04 | 217 | 164 | 7 | MM861 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 4.82e-04 | 58 | 164 | 4 | M178 | |
| Coexpression | DER_IFN_BETA_RESPONSE_UP | 4.82e-04 | 103 | 164 | 5 | M13453 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 5.09e-04 | 365 | 164 | 9 | M39018 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ATPSCKMT PLIN4 CACNA1C COL4A5 COL5A1 COL5A2 NPTX1 COL11A1 COL11A2 SLC4A7 PREB STX18 CSNK1G3 AHNAK TJP2 ABCG8 COL1A1 COL1A2 | 5.31e-04 | 1198 | 164 | 18 | MM1062 |
| Coexpression | MA_RAT_AGING_DN | 5.42e-04 | 161 | 164 | 6 | M46419 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 5.79e-04 | 163 | 164 | 6 | M2769 | |
| Coexpression | LIAO_METASTASIS | FLNA COL11A2 GRK6 DLGAP4 RRAS SH2B1 CBX6 DMKN SYNCRIP COL1A1 COL1A2 | 6.20e-04 | 540 | 164 | 11 | M13809 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | COL4A5 COL4A6 COL5A1 COL6A2 COL11A1 COL16A1 SFSWAP PARD3B EGFL6 NRXN3 COL1A1 COL1A2 | 3.38e-08 | 197 | 160 | 12 | gudmap_developingGonad_e16.5_epididymis_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | COL4A6 COL5A1 COL6A2 COL11A1 COL16A1 COL27A1 PARD3B EGFL6 TNNT1 COL1A1 COL1A2 | 1.69e-06 | 234 | 160 | 11 | gudmap_developingGonad_e18.5_epididymis_1000_k5 |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.04e-05 | 66 | 160 | 6 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - cervix | 1.04e-05 | 66 | 160 | 6 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 2.02e-05 | 74 | 160 | 6 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | COL6A2 NPTX2 COL15A1 COL16A1 COL5A3 DMKN TPPP3 COL1A1 COL1A2 | 6.21e-05 | 229 | 160 | 9 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 6.96e-05 | 92 | 160 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | COL4A4 ABCC3 COL6A2 NPTX2 COL15A1 COL16A1 AOX1 COL5A3 COLEC11 DMKN AHNAK SHE TPPP3 ALDH2 SYNCRIP COL1A1 COL1A2 | 9.05e-05 | 783 | 160 | 17 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 9.35e-05 | 97 | 160 | 6 | GSM777043_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | COL2A1 CACNA1C COL6A2 COL16A1 APC2 EGFL6 COL24A1 NRXN3 EIF2S3 CGN NINL TJP2 TPPP3 PLCH1 PATJ TNNT1 ALDH5A1 COL1A1 COL1A2 | 1.60e-04 | 984 | 160 | 19 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.74e-04 | 69 | 160 | 5 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 1.86e-04 | 70 | 160 | 5 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.07e-04 | 159 | 160 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | PLIN4 CACNA1C FLNA FLNC NPTX2 COL15A1 COL16A1 MCHR1 AOX1 RRAS COLEC11 AHNAK C1QTNF9 ALDH2 TNNT1 COL1A1 | 2.11e-04 | 761 | 160 | 16 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 2.12e-04 | 72 | 160 | 5 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 2.27e-04 | 73 | 160 | 5 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 2.30e-04 | 40 | 160 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_200 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 2.50e-04 | 116 | 160 | 6 | ratio_EB_vs_SC_500_K5 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL16A1 COL6A6 COL27A1 EGFL6 FRMPD3 PLP1 COL1A1 COL1A2 | 1.25e-14 | 189 | 164 | 14 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL16A1 COL6A6 COL27A1 EGFL6 FRMPD3 PLP1 COL1A1 COL1A2 | 1.25e-14 | 189 | 164 | 14 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL5A2 COL6A2 FLNC COL9A1 COL11A1 COL15A1 COL6A6 COL27A1 EGFL6 DMKN PLP1 COL1A1 | 1.44e-14 | 191 | 164 | 14 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL13A1 COL15A1 COL16A1 COL5A3 COL6A5 COL24A1 ABCC12 PURG COL1A2 | 2.22e-14 | 197 | 164 | 14 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A5 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL15A1 COL16A1 COL5A3 EGFL6 C1QTNF1 COL1A1 COL1A2 | 2.38e-14 | 198 | 164 | 14 | 1b90d632e59c3c47b936e829cceeb0334f05f34f |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL2A1 CACNA1C COL5A1 COL5A2 COL6A2 COL9A1 IL16 COL11A1 COL11A2 COL15A1 COL16A1 AOX1 ABCA10 COL1A2 | 2.73e-14 | 200 | 164 | 14 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL2A1 CACNA1C COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL15A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 2.75e-13 | 188 | 164 | 13 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL5A2 COL6A2 COL11A1 COL16A1 COL6A6 COL27A1 EGFL6 FRMPD3 PLP1 COL1A1 COL1A2 | 3.37e-13 | 191 | 164 | 13 | 5271198116343c07202649889057e5774d7fdde3 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A5 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL15A1 COL16A1 COL5A3 C1QTNF1 COL1A1 COL1A2 | 5.34e-13 | 198 | 164 | 13 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | COL5A1 COL5A2 COL6A2 COL15A1 COL16A1 MCHR1 COL5A3 EGFL6 C1QTNF1 AGAP2 COL1A1 COL1A2 | 1.58e-12 | 168 | 164 | 12 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | COL5A1 COL5A2 COL6A2 COL11A1 COL15A1 COL6A6 AOX1 COL5A3 ABCC8 PLP1 COL1A1 COL1A2 | 4.08e-12 | 182 | 164 | 12 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL11A1 COL13A1 COL15A1 COL16A1 COL27A1 COL5A3 PLP1 COL1A1 COL1A2 | 4.36e-12 | 183 | 164 | 12 | 803376f5260de83c48d4f7301278d078a32b3e6e |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL11A1 COL13A1 COL15A1 COL16A1 COL27A1 COL5A3 PLP1 COL1A1 COL1A2 | 4.36e-12 | 183 | 164 | 12 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL11A1 COL13A1 COL15A1 COL16A1 COL27A1 COL5A3 PLP1 COL1A1 COL1A2 | 4.36e-12 | 183 | 164 | 12 | cc7f5a17b40e8d901885174922e5fa8877643071 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL13A1 COL15A1 COL16A1 COL6A6 AOX1 COL6A5 ABCA10 COL1A1 COL1A2 | 5.28e-12 | 186 | 164 | 12 | 5473283fb95cee556b1f6934cf72169b676b5bcc |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | COL4A3 COL4A4 COL5A1 COL5A2 COL6A2 IL16 COL15A1 COL6A6 AOX1 ABCA10 COL1A1 COL1A2 | 5.62e-12 | 187 | 164 | 12 | 4ea486991f66c29728d127171a07b81404ec0b78 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 6.37e-12 | 189 | 164 | 12 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | COL5A1 COL5A2 COL6A2 FLNC COL16A1 COL6A6 ABCA10 COLEC11 DMKN SNTB1 COL1A1 COL1A2 | 6.78e-12 | 190 | 164 | 12 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A5 COL5A1 COL5A2 COL6A2 COL15A1 COL16A1 COL6A6 COL5A3 C1QTNF1 PLOD1 COL1A1 COL1A2 | 7.67e-12 | 192 | 164 | 12 | beac6b3c191b11add8e39e8d04562b478ea8929e |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 7.67e-12 | 192 | 164 | 12 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL15A1 COL16A1 COL6A6 COL6A5 ST8SIA1 COL1A1 COL1A2 | 8.15e-12 | 193 | 164 | 12 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 8.15e-12 | 193 | 164 | 12 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 8.67e-12 | 194 | 164 | 12 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 8.67e-12 | 194 | 164 | 12 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A5 HSPE1 COL5A1 COL5A2 COL11A1 COL11A2 COL15A1 COL16A1 PLOD1 COL1A1 COL1A2 | 9.20e-12 | 195 | 164 | 12 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL13A1 COL15A1 COL16A1 COL6A6 AOX1 COL6A5 ABCA10 COL1A1 COL1A2 | 9.77e-12 | 196 | 164 | 12 | 42e9828222a9663525d571633e8a454c30bfa7f8 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 COL5A3 ABCA10 COL1A1 COL1A2 | 9.77e-12 | 196 | 164 | 12 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 PARD3B ABCA10 COL1A1 COL1A2 | 9.77e-12 | 196 | 164 | 12 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 C1QTNF1 COL1A1 COL1A2 | 1.10e-11 | 198 | 164 | 12 | 1f956e369e00d37835095a001db4b62a79014532 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 C1QTNF1 COL1A1 COL1A2 | 1.10e-11 | 198 | 164 | 12 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 PARD3B ABCA10 COL1A1 COL1A2 | 1.10e-11 | 198 | 164 | 12 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COL5A2 COL6A2 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 EGFL6 COL1A1 COL1A2 | 1.10e-11 | 198 | 164 | 12 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | CACNA1C COL5A1 COL5A2 COL6A2 FLNC COL16A1 COL6A6 AOX1 COL5A3 EGFL6 COL1A1 COL1A2 | 1.17e-11 | 199 | 164 | 12 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL13A1 COL15A1 COL6A6 ST8SIA1 ABCA10 COL1A1 COL1A2 | 1.24e-11 | 200 | 164 | 12 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL13A1 COL15A1 ST8SIA1 ABCA10 COL24A1 COL1A1 COL1A2 | 1.24e-11 | 200 | 164 | 12 | fb53be20392a8309a7393774c774a1b1aec6e676 |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | FOXD2 COL4A5 COL4A6 COL5A1 COL6A2 FLNC COL13A1 COL15A1 C1QTNF1 COL1A1 COL1A2 | 1.28e-11 | 153 | 164 | 11 | e9c6fb5c41adb6595c66c3a917fe455348279e54 |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | FOXD2 COL4A5 COL4A6 COL5A1 COL6A2 FLNC COL13A1 COL15A1 C1QTNF1 COL1A1 COL1A2 | 1.28e-11 | 153 | 164 | 11 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | FOXD2 COL4A5 COL4A6 COL5A1 COL6A2 FLNC COL13A1 COL15A1 C1QTNF1 COL1A1 COL1A2 | 1.28e-11 | 153 | 164 | 11 | 2513edfae62a44e51d3556675a096723194c966c |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | FOXD2 COL4A5 COL4A6 COL6A2 FLNC COL13A1 COL15A1 AOX1 C1QTNF1 COL1A1 COL1A2 | 1.95e-11 | 159 | 164 | 11 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | COL4A3 COL4A4 COL5A1 COL5A2 COL6A2 COL15A1 COL6A6 AOX1 ST8SIA1 ABCA10 COL1A2 | 7.03e-11 | 179 | 164 | 11 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL11A1 COL13A1 COL15A1 COL16A1 COL5A3 PLP1 COL1A1 COL1A2 | 7.46e-11 | 180 | 164 | 11 | 935c091bbcd6d10b81dc4731779e5bd98205c99f |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL11A1 COL13A1 COL15A1 COL16A1 COL5A3 PLP1 COL1A1 COL1A2 | 7.46e-11 | 180 | 164 | 11 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | COL5A1 COL5A2 COL6A2 FLNC COL9A1 COL15A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 9.45e-11 | 184 | 164 | 11 | 0b336489c10e8c3c957795dd845454f03404382b |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | COL5A1 COL5A2 COL6A2 IL16 COL15A1 COL16A1 AOX1 COL5A3 ABCA10 COL1A1 COL1A2 | 9.45e-11 | 184 | 164 | 11 | 2b7e6f91e11c228f0521e099886867d9e998e78d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 1.26e-10 | 189 | 164 | 11 | a153b83314cf52808f685296cff8c95af3f4983d |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | COL5A1 COL5A2 FLNA COL6A2 COL13A1 COL16A1 COL27A1 SUGP2 CHST2 COL1A1 COL1A2 | 1.26e-10 | 189 | 164 | 11 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 ABCA10 COL1A1 COL1A2 | 1.33e-10 | 190 | 164 | 11 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 1.41e-10 | 191 | 164 | 11 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 1.49e-10 | 192 | 164 | 11 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL4A3 COL4A4 COL5A1 COL5A2 COL6A2 COL15A1 AOX1 COL5A3 ABCA10 COL24A1 COL1A2 | 1.49e-10 | 192 | 164 | 11 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL13A1 COL6A6 AOX1 PARD3B ABCA10 COL1A2 | 1.49e-10 | 192 | 164 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 1.49e-10 | 192 | 164 | 11 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | COL4A3 COL4A4 COL5A1 COL5A2 COL6A2 SLC4A7 COL15A1 COL5A3 ABCA10 COL1A1 COL1A2 | 1.49e-10 | 192 | 164 | 11 | 60b1312e84f6d6448365a952469c506c00b5fe93 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ST8SIA1 COL1A1 COL1A2 | 1.49e-10 | 192 | 164 | 11 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 COL6A5 ST8SIA1 COL1A1 COL1A2 | 1.49e-10 | 192 | 164 | 11 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 COL5A3 ABCA10 COL1A1 COL1A2 | 1.58e-10 | 193 | 164 | 11 | 9ab47b360bee1d4f1092c2269e58acebe9584021 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 ST8SIA1 RPL5 COL1A1 COL1A2 | 1.67e-10 | 194 | 164 | 11 | 8c37bedb23285735ff3828db3889897fada8c95d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 COL6A5 ST8SIA1 COL1A1 COL1A2 | 1.67e-10 | 194 | 164 | 11 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1C COL5A1 COL5A2 COL6A2 IL16 AOX1 COL5A3 TUB ABCA10 COL1A1 COL1A2 | 1.76e-10 | 195 | 164 | 11 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ABCA10 COL1A1 COL1A2 | 1.76e-10 | 195 | 164 | 11 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL13A1 COL16A1 COL6A6 COL6A5 ST8SIA1 COL1A2 | 1.76e-10 | 195 | 164 | 11 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL6A5 ABCA10 COL1A1 COL1A2 | 1.76e-10 | 195 | 164 | 11 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL5A1 ABCC3 COL5A2 FLNA COL6A2 NPTX1 C1QTNF9 C1QTNF1 CHST2 PATJ COL1A2 | 1.86e-10 | 196 | 164 | 11 | b8b9801181d7604871b48aebacb295d0a57a5eaf |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | COL5A1 COL5A2 COL6A2 COL13A1 COL6A6 PARD3B COL24A1 HECTD2 CHST2 COL1A1 COL1A2 | 1.86e-10 | 196 | 164 | 11 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A4 COL5A1 COL5A2 COL6A2 SLC4A7 COL15A1 COL16A1 COL27A1 COL5A3 COL1A1 COL1A2 | 1.96e-10 | 197 | 164 | 11 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL6A2 COL11A1 COL15A1 COL16A1 COL5A3 EGFL6 SLC7A8 COL1A1 COL1A2 | 1.96e-10 | 197 | 164 | 11 | c165c6fd12dc649b39e920d8528e2eb65c61956b |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A4 COL5A1 COL5A2 COL6A2 SLC4A7 COL15A1 COL16A1 COL27A1 COL5A3 COL1A1 COL1A2 | 1.96e-10 | 197 | 164 | 11 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A5 COL5A1 COL5A2 COL6A2 COL11A1 COL16A1 COL27A1 CHST2 PLOD1 COL1A1 COL1A2 | 1.96e-10 | 197 | 164 | 11 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CACNA1C ABCC3 COL5A2 COL6A6 PARD3B SLC7A8 COL24A1 HECTD2 CHST2 COL1A1 COL1A2 | 1.96e-10 | 197 | 164 | 11 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A5 HSPE1 COL5A1 COL5A2 COL6A2 FLNC COL15A1 COL5A3 TPPP3 COL1A1 COL1A2 | 2.07e-10 | 198 | 164 | 11 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 ABCA10 COL1A1 COL1A2 | 2.07e-10 | 198 | 164 | 11 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL16A1 COL27A1 COL1A1 COL1A2 | 2.07e-10 | 198 | 164 | 11 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL16A1 COL27A1 COL1A1 COL1A2 | 2.07e-10 | 198 | 164 | 11 | 1beed34f469aad07e8f674f0b668d6e1e916403c |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | CACNA1C COL5A1 COL5A2 COL6A2 COL16A1 COL6A6 COL27A1 AOX1 ABCA10 COL1A1 COL1A2 | 2.07e-10 | 198 | 164 | 11 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COL5A2 COL6A2 COL9A1 COL11A1 COL11A2 COL16A1 COL27A1 COL1A1 COL1A2 | 2.07e-10 | 198 | 164 | 11 | 985022c1722ab7b67675ebe814022a439e715b5e |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | COL4A4 CACNA1C COL5A1 COL5A2 COL6A2 COL16A1 COL27A1 COLEC11 C1QTNF1 COL1A1 COL1A2 | 2.07e-10 | 198 | 164 | 11 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 AOX1 COL5A3 COL6A5 COL1A1 COL1A2 | 2.19e-10 | 199 | 164 | 11 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL6A2 COL16A1 COL6A6 COL5A3 EGFL6 TPPP3 PLP1 COL1A1 COL1A2 | 2.19e-10 | 199 | 164 | 11 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | FOXD2 PLIN4 COL4A6 COL5A1 FLNC COL13A1 COL15A1 C1QTNF1 KLHDC7A COL1A1 | 2.22e-10 | 149 | 164 | 10 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL6A2 COL6A6 COL5A3 EGFL6 DMKN TPPP3 PLP1 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL16A1 COL6A6 COL6A5 EGFL6 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 COL16A1 COL6A6 AOX1 COL5A3 EGFL6 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL6A2 COL6A6 COL5A3 EGFL6 DMKN TPPP3 PLP1 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | de1d193f773f4e2927baa6fc38d29754b015c6e6 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL6A2 FLNC COL6A6 COL5A3 EGFL6 TPPP3 PLP1 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 ABCA10 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL16A1 COL6A6 AOX1 ABCA10 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL6A2 FLNC COL6A6 COL5A3 EGFL6 TPPP3 PLP1 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | 76f3043cb88071256ff661885fe5a82a54f5b733 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CACNA1C COL5A1 COL5A2 COL6A2 IL16 COL13A1 COL15A1 COL6A5 ABCA10 COL1A1 COL1A2 | 2.31e-10 | 200 | 164 | 11 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL5A3 COL6A5 COL24A1 COL1A1 COL1A2 | 3.71e-10 | 157 | 164 | 10 | f147e24f2ece82e1c54750868954d09b3c461804 |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | COL4A3 COL4A4 COL4A5 COL4A6 FLNC COL13A1 COL15A1 ABCC6 COL1A1 | 7.26e-10 | 121 | 164 | 9 | 5035e071033cb76a7fc0128716755b14821e8f05 |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | COL4A3 COL4A4 COL4A5 COL4A6 FLNC COL13A1 COL15A1 ABCC6 COL1A1 | 7.26e-10 | 121 | 164 | 9 | c96115bd33455296378a257583b49442d00b39ca |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | CACNA1C COL5A1 COL5A2 COL6A2 COL13A1 COL6A6 AOX1 COL6A5 EGFL6 COL1A2 | 7.62e-10 | 169 | 164 | 10 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA1C COL4A5 COL4A6 COL5A1 COL5A2 COL27A1 COL24A1 PLP1 COL1A1 COL1A2 | 9.57e-10 | 173 | 164 | 10 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | COL4A6 COL6A2 FLNC COL13A1 COL15A1 PCDHGB2 PCDHGA10 C1QTNF1 COL1A1 | 1.04e-09 | 126 | 164 | 9 | f1f24b06d301c266226d1a59dd28585f5ac68f29 |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | COL4A6 COL6A2 FLNC COL13A1 COL15A1 PCDHGB2 PCDHGA10 C1QTNF1 COL1A1 | 1.04e-09 | 126 | 164 | 9 | fe6900eb37e4f09465a1276586c73dd38545fa2a |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | COL4A6 COL6A2 FLNC COL13A1 COL15A1 PCDHGB2 PCDHGA10 C1QTNF1 COL1A1 | 1.04e-09 | 126 | 164 | 9 | 3d507f829882d043f633db2612b76936e2042445 |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | COL4A6 COL6A2 FLNC COL13A1 COL15A1 PCDHGB2 PCDHGA10 C1QTNF1 COL1A1 | 1.04e-09 | 126 | 164 | 9 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | COL4A6 COL6A2 FLNC COL13A1 COL15A1 PCDHGB2 PCDHGA10 C1QTNF1 COL1A1 | 1.04e-09 | 126 | 164 | 9 | 2de551d7a8765afec1da8852727c79fec90f45f8 |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | COL2A1 COL9A1 COL11A1 COL11A2 COL15A1 ACACB COL27A1 ST8SIA1 TUB DMKN | 1.26e-09 | 178 | 164 | 10 | a55130670aa95a87b833dd3cd2de461d779e4c06 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | GABRD COL4A3 COL5A1 COL5A2 COL11A1 COL13A1 COL16A1 C1QTNF1 COL1A1 COL1A2 | 1.26e-09 | 178 | 164 | 10 | e32f5ed7a492edfa7073416008b1fcfae6b854ad |
| Computational | Neighborhood of CDH11 | 3.85e-06 | 25 | 106 | 5 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 2.51e-05 | 36 | 106 | 5 | GNF2_PTX3 | |
| Computational | Adhesion molecules. | 7.34e-05 | 141 | 106 | 8 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-04 | 50 | 106 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Drug | GK-101 | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 1.53e-23 | 36 | 162 | 15 | CID000161853 |
| Drug | Madecassol | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 1.32e-21 | 46 | 162 | 15 | CID000108062 |
| Drug | AC1LAKND | COL2A1 COL4A3 COL4A5 HSPE1 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 4.17e-21 | 62 | 162 | 16 | CID000470146 |
| Drug | d-indobufen | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 5.68e-21 | 50 | 162 | 15 | CID000044562 |
| Drug | ridogrel | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 1.12e-20 | 52 | 162 | 15 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 1.55e-20 | 53 | 162 | 15 | CID000023340 |
| Drug | BAPN | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 PLOD1 COL1A1 COL1A2 | 4.63e-20 | 71 | 162 | 16 | CID000001647 |
| Drug | AC1L1C2F | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 RRAS COL24A1 PLOD1 AGAP2 COL1A1 COL1A2 | 9.46e-20 | 110 | 162 | 18 | CID000001711 |
| Drug | malotilate | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 2.03e-18 | 71 | 162 | 15 | CID000004006 |
| Drug | DMSe | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 FLNA COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL5A3 COL24A1 PLOD1 COL1A1 COL1A2 | 2.85e-18 | 132 | 162 | 18 | CID000020796 |
| Drug | AC1NMZ1B | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 4.94e-18 | 75 | 162 | 15 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 7.56e-18 | 77 | 162 | 15 | CID006918182 |
| Drug | ticlopidine | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 ACACA COL27A1 COL24A1 COL1A1 COL1A2 | 2.67e-17 | 103 | 162 | 16 | CID000005472 |
| Drug | halofuginone lactate | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 3.67e-17 | 85 | 162 | 15 | CID000062891 |
| Drug | hydroxylysine | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 PLOD1 COL1A1 COL1A2 | 6.85e-17 | 109 | 162 | 16 | CID000001029 |
| Drug | 4-hydroxyproline | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 1.08e-16 | 91 | 162 | 15 | CID000000825 |
| Drug | PCR 4099 | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 ACACA COL27A1 COL24A1 TNNT1 COL1A1 COL1A2 | 1.70e-16 | 139 | 162 | 17 | CID000002806 |
| Drug | Selara | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 ABCC6 COL24A1 COL1A1 COL1A2 | 6.49e-16 | 125 | 162 | 16 | CID000150310 |
| Drug | PPACK | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 3.12e-15 | 113 | 162 | 15 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 3.57e-15 | 114 | 162 | 15 | CID000439300 |
| Drug | DL-penicillamine | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 ABCC6 COL24A1 COL1A1 COL1A2 | 3.62e-15 | 139 | 162 | 16 | CID000004727 |
| Drug | Tranilast sodium | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 4.08e-15 | 115 | 162 | 15 | CID000005527 |
| Drug | khellin | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 MCHR1 COL27A1 COL24A1 PLOD1 COL1A1 COL1A2 | 5.76e-15 | 171 | 162 | 17 | CID000003828 |
| Drug | candesartan cilexetil | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 ABCC6 COL24A1 COL1A1 COL1A2 | 7.13e-15 | 145 | 162 | 16 | CID000002540 |
| Drug | pirfenidone | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 6.44e-14 | 138 | 162 | 15 | CID000040632 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 PLCH1 COL1A1 COL1A2 | 4.66e-13 | 189 | 162 | 16 | CID000001413 |
| Drug | foscarnet | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 POLR2B COL24A1 COL1A1 COL1A2 | 5.05e-13 | 190 | 162 | 16 | CID000003414 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 6.95e-13 | 162 | 162 | 15 | CID000072363 |
| Drug | AC1Q6PCP | COL2A1 COL4A3 COL4A5 HSPE1 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 ABCC6 COL24A1 COL1A1 COL1A2 | 7.72e-13 | 230 | 162 | 17 | CID000005267 |
| Drug | AC1L1DD6 | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 2.99e-12 | 179 | 162 | 15 | CID000002299 |
| Drug | AC1L18QD | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 PHF2 COL24A1 PLCH1 PLOD1 COL1A1 COL1A2 | 2.05e-11 | 325 | 162 | 18 | CID000000213 |
| Drug | losartan | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 SLC4A7 COL13A1 COL16A1 COL27A1 ABCC6 COL24A1 ABCC8 SHE COL1A1 COL1A2 | 2.93e-11 | 378 | 162 | 19 | CID000003961 |
| Drug | isodesmosine | 6.59e-11 | 33 | 162 | 8 | CID000013811 | |
| Drug | colchine | COL2A1 GABRD COL4A3 COL4A5 HSPE1 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 PDZD2 COL1A1 COL1A2 | 2.98e-10 | 383 | 162 | 18 | CID000002833 |
| Drug | prostacyclin sodium salt | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 3.47e-10 | 250 | 162 | 15 | CID000000159 |
| Drug | hyaluronan | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 7.00e-10 | 263 | 162 | 15 | CID000024759 |
| Drug | NC-4 | 7.87e-10 | 44 | 162 | 8 | CID006420119 | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 DMKN COL1A1 COL1A2 | 9.55e-10 | 314 | 162 | 16 | CID000447989 |
| Drug | AC1L1KMJ | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 APC2 COL24A1 CGN TJP2 MARCO COL1A1 COL1A2 | 1.42e-09 | 476 | 162 | 19 | CID000030956 |
| Drug | silibinin | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 2.11e-09 | 285 | 162 | 15 | CID000005213 |
| Drug | L-3,4-dehydroproline | COL2A1 COL5A1 COL6A2 COL11A1 COL13A1 COL16A1 PLOD1 COL1A1 COL1A2 | 2.46e-09 | 73 | 162 | 9 | CID000094284 |
| Drug | desmosine | 3.73e-09 | 53 | 162 | 8 | CID000025435 | |
| Drug | 351A | 4.22e-09 | 20 | 162 | 6 | CID000122144 | |
| Drug | AC1MRIIV | 1.03e-08 | 39 | 162 | 7 | CID003518584 | |
| Drug | Y-27632 | COL2A1 COL4A3 CACNA1C COL4A5 COL4A6 COL5A1 EPRS1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 COL1A1 COL1A2 | 2.03e-08 | 444 | 162 | 17 | CID000005711 |
| Drug | PD123177 | 2.11e-08 | 43 | 162 | 7 | CID000114899 | |
| Drug | BPAT-143 | 3.66e-08 | 6 | 162 | 4 | CID000146249 | |
| Drug | pyridinoline | COL2A1 COL5A1 COL9A1 COL11A1 COL11A2 COL27A1 PLOD1 COL1A1 COL1A2 | 3.75e-08 | 99 | 162 | 9 | CID000105068 |
| Drug | chondroitin sulfate | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 COL24A1 CHST2 COL1A1 COL1A2 | 4.61e-08 | 413 | 162 | 16 | CID000024766 |
| Drug | LMWH | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 ACACA COL27A1 GRK6 POLR2B COL24A1 CSNK1G3 TNNT1 COL1A1 COL1A2 | 5.69e-08 | 663 | 162 | 20 | CID000000772 |
| Drug | aspirin | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 ACACA COL27A1 APC2 COL24A1 PLCH1 COL1A1 COL1A2 | 1.17e-07 | 563 | 162 | 18 | CID000002244 |
| Drug | 1h00 | 1.40e-07 | 56 | 162 | 7 | CID000445950 | |
| Drug | dermatan sulfate | COL2A1 COL4A3 COL4A5 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL27A1 CHST2 COL1A1 | 5.32e-07 | 220 | 162 | 11 | CID000032756 |
| Drug | Collagenase | 1.41e-06 | 4 | 162 | 3 | DB00048 | |
| Drug | methylmalonate semialdehyde | 2.96e-06 | 32 | 162 | 5 | CID000000296 | |
| Drug | Sirius red | 4.68e-06 | 35 | 162 | 5 | CID005486818 | |
| Drug | 4-aminoazobenzene | 7.55e-06 | 66 | 162 | 6 | CID000006051 | |
| Drug | ezetimibe | 1.07e-05 | 147 | 162 | 8 | CID000150311 | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.18e-05 | 196 | 162 | 9 | 4539_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 2291_UP | |
| Drug | rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 1.27e-05 | 198 | 162 | 9 | 6192_UP | |
| Drug | 1zd2 | 1.66e-05 | 45 | 162 | 5 | CID004149241 | |
| Drug | indole-3-acetaldehyde | 4.43e-05 | 28 | 162 | 4 | CID000000800 | |
| Drug | thiamine | 4.99e-05 | 134 | 162 | 7 | CID000001130 | |
| Drug | crocetane | 5.03e-05 | 2 | 162 | 2 | CID000136331 | |
| Drug | 5'-methylthioadenosine | 5.03e-05 | 2 | 162 | 2 | ctd:C008500 | |
| Drug | AC1L1J6H | 5.07e-05 | 236 | 162 | 9 | CID000004889 | |
| Drug | AC1L9HPX | 5.09e-05 | 92 | 162 | 6 | CID000445279 | |
| Drug | trapidil | 5.32e-05 | 57 | 162 | 5 | CID000005531 | |
| Drug | LS-63783 | COL2A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL9A1 COL11A1 COL11A2 COL13A1 COL16A1 COL27A1 GRK6 ABCC6 COL24A1 COL1A1 COL1A2 | 6.27e-05 | 804 | 162 | 17 | CID000000231 |
| Drug | pyrachlostrobin | GABRD COL4A5 COL4A6 COL5A1 COL5A2 FLNA FLNC COL11A1 COL16A1 COL5A3 PARD3B RRAS AHNAK TJP2 KLHDC7A PLOD1 COL1A1 | 6.98e-05 | 811 | 162 | 17 | ctd:C513428 |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.22e-05 | 192 | 162 | 8 | 5620_UP | |
| Drug | isosteviol | 7.42e-05 | 12 | 162 | 3 | ctd:C515747 | |
| Drug | maleic anhydride | 7.60e-05 | 32 | 162 | 4 | CID000007923 | |
| Drug | AC1Q641C | 8.00e-05 | 62 | 162 | 5 | CID000005005 | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 6415_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 8.33e-05 | 196 | 162 | 8 | 1558_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 4752_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 2628_UP | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 4149_UP | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 4818_UP | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 4130_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 4152_UP | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | COL2A1 CACNA1C HSPE1 ABCC3 COL9A1 SLC4A7 COL13A1 COL16A1 MNX1 ST8SIA1 SLC7A8 EIF2S3 SHE PLCH1 PATJ AGAP2 PDZD2 COL1A1 | 8.74e-05 | 909 | 162 | 18 | CID000002524 |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6200_UP | |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 4179_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 5635_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 2635_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 3606_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 3200_UP | |
| Drug | Cytarabine | COL5A1 COL5A2 COL6A2 FLNC COL9A1 COL13A1 RRAS EGFL6 AHNAK PLCH1 PLOD1 PLP1 COL1A1 COL1A2 | 9.99e-05 | 598 | 162 | 14 | ctd:D003561 |
| Drug | haloperidol | COL2A1 GABRD CACNA1C COL5A1 COL11A2 ACACA MCHR1 COL27A1 ABCC8 RAB40C COL1A1 | 1.26e-04 | 394 | 162 | 11 | CID000003559 |
| Drug | 2-amino-4,6-dinitrotoluene | 1.43e-04 | 70 | 162 | 5 | ctd:C035208 | |
| Drug | CP-331 | 1.50e-04 | 3 | 162 | 2 | CID000130967 | |
| Drug | aza-C-nucleosides | 1.51e-04 | 38 | 162 | 4 | CID000001336 | |
| Drug | ascorbate-2-phosphate | 1.51e-04 | 15 | 162 | 3 | ctd:C011669 | |
| Drug | destomycin A | 1.52e-04 | 112 | 162 | 6 | CID000003659 | |
| Drug | Magnesium | 1.53e-04 | 71 | 162 | 5 | ctd:D008274 | |
| Drug | AC1L24VO | 1.85e-04 | 40 | 162 | 4 | CID000014967 | |
| Drug | carboxyphosphamide | 1.85e-04 | 16 | 162 | 3 | CID000031515 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | COL4A5 COL5A1 COL5A2 FLNA COL9A1 COL11A1 PLOD1 COL1A1 COL1A2 | 1.31e-11 | 53 | 162 | 9 | C4707243 |
| Disease | Stickler syndrome | 4.36e-09 | 5 | 162 | 4 | cv:C0265253 | |
| Disease | myopathy (implicated_via_orthology) | 8.04e-09 | 48 | 162 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | Hereditary hearing loss and deafness | COL2A1 COL4A3 COL4A4 COL4A5 COL9A1 COL11A1 COL11A2 PDHA1 TRIOBP SUCLA2 | 8.77e-09 | 146 | 162 | 10 | cv:C0236038 |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 1.62e-07 | 3 | 162 | 3 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 1.62e-07 | 3 | 162 | 3 | C0220679 | |
| Disease | Alport syndrome | 1.62e-07 | 3 | 162 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.62e-07 | 3 | 162 | 3 | cv:CN076135 | |
| Disease | collagen disease (implicated_via_orthology) | 4.19e-07 | 12 | 162 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Hematuria, Benign Familial | 6.47e-07 | 4 | 162 | 3 | C0241908 | |
| Disease | Alport Syndrome | 6.47e-07 | 4 | 162 | 3 | C1567741 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.51e-06 | 16 | 162 | 4 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.51e-06 | 16 | 162 | 4 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.51e-06 | 16 | 162 | 4 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.51e-06 | 16 | 162 | 4 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.51e-06 | 16 | 162 | 4 | C0025237 | |
| Disease | Alport Syndrome, X-Linked | 1.61e-06 | 5 | 162 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.61e-06 | 5 | 162 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.61e-06 | 5 | 162 | 3 | C1567744 | |
| Disease | Van Buchem disease | 1.97e-06 | 17 | 162 | 4 | C0432272 | |
| Disease | Early Pregnancy Loss | 2.46e-06 | 109 | 162 | 7 | C3830362 | |
| Disease | Spontaneous abortion | 2.46e-06 | 109 | 162 | 7 | C0000786 | |
| Disease | Miscarriage | 2.46e-06 | 109 | 162 | 7 | C4552766 | |
| Disease | Abortion, Tubal | 2.46e-06 | 109 | 162 | 7 | C0000822 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.18e-06 | 19 | 162 | 4 | DOID:2256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 3.18e-06 | 19 | 162 | 4 | C0029422 | |
| Disease | Dyschondroplasias | 3.18e-06 | 19 | 162 | 4 | C0013366 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 3.21e-06 | 6 | 162 | 3 | DOID:13359 (implicated_via_orthology) | |
| Disease | Multiple Epiphyseal Dysplasia | 3.96e-06 | 20 | 162 | 4 | C0026760 | |
| Disease | Disproportionate short stature | 4.29e-06 | 77 | 162 | 6 | C0878659 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 5.59e-06 | 7 | 162 | 3 | C1846545 | |
| Disease | Bleeding tendency | 5.59e-06 | 7 | 162 | 3 | C1458140 | |
| Disease | JT interval, response to sulfonylurea | 7.15e-06 | 23 | 162 | 4 | EFO_0007885, EFO_0007922 | |
| Disease | Ehlers-Danlos syndrome | 8.92e-06 | 8 | 162 | 3 | cv:C0013720 | |
| Disease | mental development measurement | 1.01e-05 | 25 | 162 | 4 | EFO_0008230 | |
| Disease | Degenerative polyarthritis | 1.28e-05 | 93 | 162 | 6 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 1.28e-05 | 93 | 162 | 6 | C0086743 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.33e-05 | 9 | 162 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 2.40e-05 | 277 | 162 | 9 | C0009404 | |
| Disease | Sensory hearing loss | 2.60e-05 | 11 | 162 | 3 | C1691779 | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 3.00e-05 | 2 | 162 | 2 | C1839884 | |
| Disease | Ehlers-Danlos syndrome type 1 | 3.00e-05 | 2 | 162 | 2 | C0268335 | |
| Disease | Ehlers-Danlos syndrome type 2 | 3.00e-05 | 2 | 162 | 2 | C0268336 | |
| Disease | Fibrochondrogenesis | 3.00e-05 | 2 | 162 | 2 | C0265282 | |
| Disease | Alport syndrome, recessive type | 3.00e-05 | 2 | 162 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 3.00e-05 | 2 | 162 | 2 | C2931253 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 3.00e-05 | 2 | 162 | 2 | C0268345 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 3.00e-05 | 2 | 162 | 2 | C4520892 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 3.00e-05 | 2 | 162 | 2 | C4551623 | |
| Disease | Ehlers-Danlos syndrome classic type | 3.00e-05 | 2 | 162 | 2 | C4225429 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 3.00e-05 | 2 | 162 | 2 | C0403440 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 3.00e-05 | 2 | 162 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 3.00e-05 | 2 | 162 | 2 | cv:C0268362 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 3.00e-05 | 2 | 162 | 2 | cv:C0268358 | |
| Disease | Stickler syndrome, type 3 | 3.00e-05 | 2 | 162 | 2 | C1861481 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 3.00e-05 | 2 | 162 | 2 | 259420 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | benign familial hematuria (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Megaepiphyseal dwarfism | 3.00e-05 | 2 | 162 | 2 | C1855310 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 3.00e-05 | 2 | 162 | 2 | C4746745 | |
| Disease | Ehlers-Danlos syndrome, classic type | 3.00e-05 | 2 | 162 | 2 | cv:C4225429 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | Benign familial hematuria | 3.00e-05 | 2 | 162 | 2 | cv:C0241908 | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | Leiomyoma, Epithelioid | 3.00e-05 | 2 | 162 | 2 | C0086533 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 3.00e-05 | 2 | 162 | 2 | 166220 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 3.00e-05 | 2 | 162 | 2 | 166210 | |
| Disease | Colorectal Carcinoma | PCSK2 COL4A6 ABCC3 FLNC ACACA SELENBP1 ABCA13 APC2 ABCA10 ABCC6 DMKN FCN2 ABCC8 ALDH2 | 3.55e-05 | 702 | 162 | 14 | C0009402 |
| Disease | osteoarthritis (implicated_via_orthology) | 7.04e-05 | 15 | 162 | 3 | DOID:8398 (implicated_via_orthology) | |
| Disease | Cleft Palate | 8.58e-05 | 81 | 162 | 5 | C0008925 | |
| Disease | Blood Coagulation Disorders | 8.63e-05 | 16 | 162 | 3 | C0005779 | |
| Disease | skin disease (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | pyruvate decarboxylase deficiency (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:3649 (implicated_via_orthology) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 8.95e-05 | 3 | 162 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | Alport syndrome (is_implicated_in) | 8.95e-05 | 3 | 162 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Ehlers-Danlos syndrome classic type 1 (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:14720 (implicated_via_orthology) | |
| Disease | Stickler syndrome (is_implicated_in) | 1.78e-04 | 4 | 162 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | OSTEOPOROSIS | 1.78e-04 | 4 | 162 | 2 | 166710 | |
| Disease | neurexin-3-beta measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0020597 | |
| Disease | hearing impairment | 2.11e-04 | 98 | 162 | 5 | C1384666 | |
| Disease | Renal glomerular disease | 2.65e-04 | 23 | 162 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.65e-04 | 23 | 162 | 3 | C4521256 | |
| Disease | Sarcosine measurement | 2.65e-04 | 23 | 162 | 3 | EFO_0021668 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.65e-04 | 23 | 162 | 3 | C0018784 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 2.96e-04 | 5 | 162 | 2 | C0268358 | |
| Disease | Malignant Cystosarcoma Phyllodes | 2.96e-04 | 5 | 162 | 2 | C0600066 | |
| Disease | Stickler syndrome, type 1 | 2.96e-04 | 5 | 162 | 2 | C2020284 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Phyllodes Tumor | 2.96e-04 | 5 | 162 | 2 | C0010701 | |
| Disease | Lobstein Disease | 2.96e-04 | 5 | 162 | 2 | C0023931 | |
| Disease | muscular disease (implicated_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome | 2.96e-04 | 5 | 162 | 2 | C0013720 | |
| Disease | Osteoporosis | 4.43e-04 | 6 | 162 | 2 | cv:C0029456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVGGKRGVTADGDRV | 106 | A6NKX1 | |
| GKIGGDSGLSVRGKQ | 266 | O60825 | |
| GKRLDAGLTNGFGGA | 816 | O95696 | |
| LGFQGEKGVKGDVGL | 221 | Q14031 | |
| GFKGTKGRDGLIGNI | 1091 | Q14031 | |
| IVSRGGNSHGGKKGN | 321 | Q8IUX8 | |
| GAGFDLEGGKKAGSR | 11 | A8MYA2 | |
| LNLKVIDKGAGGGGA | 176 | O95503 | |
| GVKGIPGRQGAAGLK | 496 | Q01955 | |
| GLNGLKGQQGRRGKT | 821 | Q01955 | |
| KGEVLGLLGHNGAGK | 1231 | Q8WWZ4 | |
| RAGVPGLKGEKGNFG | 591 | Q07092 | |
| GLKGEKGNFGEAGPA | 596 | Q07092 | |
| GAAGQKGQAGEKGRA | 1371 | Q07092 | |
| GVSRGSGGAEGKRKQ | 1221 | Q6F5E8 | |
| VVAVGSGSKGKGGEI | 46 | P61604 | |
| FSGIDGARGPKGNKG | 1061 | P53420 | |
| KGECFGLLGVNGAGK | 4746 | Q86UQ4 | |
| KASEGGGGKGIRKVN | 311 | Q13085 | |
| DVITGRGHGGKIKSG | 116 | Q9H221 | |
| IKVGGSGVNVNAKGL | 251 | Q09666 | |
| SGAKAGGGKGAGSRL | 196 | Q99490 | |
| LGALGGEKALGGLAK | 596 | Q8N283 | |
| LAGLKGEGSRGKEAG | 1376 | Q8TEK3 | |
| GGGACSAKKERGGAA | 1276 | Q5TGY3 | |
| VRDGGKRVGSGAQKT | 196 | Q9UBU7 | |
| GGSLSVAAGGKKAEA | 186 | O43633 | |
| SLEGTAGKVGGNGSK | 156 | Q9Y2H0 | |
| RRVGGAFGGKVLKTG | 801 | Q06278 | |
| GIAAGSSGKGRGAKR | 286 | Q9UBL3 | |
| GAKGEQGEAGQKGDA | 846 | P02458 | |
| GAGGGGSKGNSLKRS | 246 | Q96S21 | |
| AAGKRDGKAPAGGNG | 906 | Q9Y5G8 | |
| IKGAGGKAFCAGGDI | 86 | Q6NVY1 | |
| GEKVGIVGRTGAGKS | 1316 | O15438 | |
| EAGSGGGGVALKKEI | 26 | Q9UHI5 | |
| EARAGGGRKQPGSGK | 101 | Q15818 | |
| SEGGGGKGIRKAESA | 456 | O00763 | |
| GGKAEQKGTLKHGGL | 886 | Q8TEW8 | |
| GGEERLKGLGEGSKQ | 571 | Q02779 | |
| KNLQLGVGRSKGGGG | 26 | Q6DN14 | |
| KSEAGARGGGQGSKE | 371 | Q7L2J0 | |
| ARGGGQGSKEKGRGS | 376 | Q7L2J0 | |
| AAQEAEKQKGGGGGA | 306 | P50219 | |
| KRGEIIAKQGGGGGG | 381 | P52272 | |
| GAGATAGLDRGAKGQ | 41 | Q5U5R9 | |
| PGANGEKGARGVAGK | 861 | P12107 | |
| QGLPGAAGKEGAKGD | 996 | P12107 | |
| GAAGAEGRQGEKGAK | 1366 | P12107 | |
| EGRQGEKGAKGEAGA | 1371 | P12107 | |
| GKVTYGQKRAAGGGS | 686 | Q92499 | |
| GRGGNVGGKRKADGY | 556 | O60506 | |
| GDLGEIGLNKGRKLG | 266 | Q9BRR8 | |
| LRAAAMGEKKEGGGG | 6 | Q8IVT5 | |
| AAGKRDGKAPAGGNG | 911 | Q9Y5H3 | |
| AAGKRDGKAPAGGNG | 906 | Q9Y5G2 | |
| KEKGKGLGFSIAGGR | 591 | O15018 | |
| GVGGKRGVTADGDRV | 106 | Q8IWN6 | |
| KVRAGGTGLERGVAG | 2316 | Q14315 | |
| ETRGGVGVGGGRKKK | 191 | Q9NP08 | |
| KGQAKGLGFSIVGGK | 221 | Q14005 | |
| GGKDKGRLFQGQLSG | 1221 | Q9Y4C0 | |
| GVKGVDGIRGLKGHK | 721 | P13942 | |
| ASGEKGARGLSGKSG | 821 | P13942 | |
| KGEKGIGGAVTATDG | 146 | P25208 | |
| TKKEGAARSGGQGGI | 401 | O14764 | |
| KERLGGGLGVAGGNS | 11 | Q9NPJ6 | |
| LEALKVKQGGRGAGA | 661 | Q9Y5S2 | |
| GGGGGLLHKKTQQEG | 166 | P78316 | |
| GKKIGCGNFGELRLG | 46 | Q9Y6M4 | |
| GIGIQGTDKEGGAKG | 316 | Q8NBF2 | |
| GAGKRNVLIFDLGGG | 191 | P48741 | |
| VEKGTSAGGGQKVRL | 66 | Q02809 | |
| EKGLRGETGPQGQKG | 111 | P0C862 | |
| GGAGRSAEQSRGAGK | 1446 | O95996 | |
| KNGDKGHAGLAGARG | 506 | P08123 | |
| AAGQPGAKGERGAKG | 731 | P08123 | |
| DRGLQGKYGKTGSAG | 106 | Q9BXJ1 | |
| TKADGANALGGKGAG | 216 | Q13936 | |
| NGGGGGKQSKQEIHR | 76 | Q8WUU5 | |
| VGKAIGKEAGGAAGS | 51 | Q6E0U4 | |
| PKGEAGTNGKRGERG | 61 | Q15485 | |
| KGAGGQGKVASKIVG | 996 | P21333 | |
| VGKQATGEVAGKGGP | 1106 | Q5JV73 | |
| LGGDFKGVGKGSLAA | 41 | P51659 | |
| QKGSKGEQGRQGRSG | 1526 | A8TX70 | |
| GLQGEQGVKGDKGDT | 466 | P29400 | |
| KNGTDGQKGKLGRIG | 326 | P12110 | |
| GPRGLAGEVGNKGAK | 451 | P12110 | |
| AGEVGNKGAKGDRGL | 456 | P12110 | |
| GSKGVGAGNHGAKAN | 71 | Q86UU0 | |
| EATKEKKRGGGGGRR | 896 | Q6PD62 | |
| EKGLRGETGPQGQKG | 111 | B2RNN3 | |
| KGDRGGIGEKGAEGT | 776 | P05997 | |
| EGRQGEKGAKGEAGL | 1401 | P20908 | |
| GKQGKAGAPGRRGVQ | 1406 | Q8IZC6 | |
| GDKGQKGSVGRHGKI | 71 | Q9BWP8 | |
| GLKGSKGDTGLQGQQ | 346 | Q9UEW3 | |
| KGDTGLQGQQGRKGE | 351 | Q9UEW3 | |
| KGDQGVKGSSGEQGV | 396 | Q9UEW3 | |
| ESSGGRGLKKGRGQK | 121 | Q8WYH8 | |
| MKKGVGRAVGLGGGS | 6 | Q99705 | |
| KPQRKGSGEERGGQG | 116 | Q5VTJ3 | |
| RGITGIVGDKGEKGA | 471 | P20849 | |
| GGVAGGSILKGVLKV | 276 | Q2VIR3 | |
| LLGQKGEKGDAGNSI | 366 | Q5TAT6 | |
| VLLKAREGGGGNRKG | 11 | P43250 | |
| KGARGPNGSVGEKGD | 681 | P39059 | |
| KQSGGAGQYGKVIGV | 541 | Q96RP9 | |
| QYSVGGIGQKGGLEK | 191 | Q15020 | |
| GTSGNRGLQGEKGEK | 716 | P25940 | |
| GSVGRKGAKGQEGFP | 1656 | A6NMZ7 | |
| GGKNVGGSGLSKSRL | 16 | Q9UJV8 | |
| AAGKRDGKAPAGGNG | 906 | Q9Y5H4 | |
| SLKAGGVLNKGCGVG | 566 | Q6ZVC0 | |
| LTGRRGGCAKGKGGS | 136 | P29803 | |
| LLRQGLKTDAGGGAG | 386 | O60548 | |
| TGAAKVAKGAVQGGL | 856 | Q96Q06 | |
| GGGGGKKSLSARNAA | 16 | Q96NL0 | |
| GALAETGAGAKKGRG | 101 | P82675 | |
| AVGNGKGAAGFSIGK | 246 | P82675 | |
| AGKGVGGGSADLIRN | 196 | O15211 | |
| LRLSRGGGALKDGAG | 231 | Q9NRF2 | |
| GGGALKDGAGMVQRE | 236 | Q9NRF2 | |
| AEVGARAGSGGKKEA | 546 | Q12872 | |
| LKQELGGLGISIKGG | 116 | Q13884 | |
| GAGEGQGPKKQTRLG | 1001 | P07814 | |
| AQKFRKGAGKGRVGG | 261 | P13805 | |
| KSGEIKGNGSGGSRE | 391 | Q9Y6M7 | |
| RKADAGGLGISIKGG | 91 | Q13424 | |
| GVKQSGLGREGSKYG | 506 | P51649 | |
| KGEAVRGGRRGKKGA | 41 | O14598 | |
| AAHGARKNGGGSGKS | 826 | O75151 | |
| RKNGGGSGKSAGKRL | 831 | O75151 | |
| TGMGGKAGNKGAVGI | 656 | O15056 | |
| AGEKVGIVGRTGAGK | 1291 | O95255 | |
| KIANGGGTGAGKAEC | 201 | P57071 | |
| GGKDKGRLFQGQLSG | 216 | Q9HDB5 | |
| KVVVSGGRGLKSGEN | 216 | P13804 | |
| GGGSGGVGKKEQLSV | 961 | Q7Z3K3 | |
| ALGAKGALKAGVGEG | 21 | Q9UPR0 | |
| GGKVTMDGRVNGGLN | 381 | O15355 | |
| ARGGQGAKKSAIGQR | 241 | P30876 | |
| VGNGGILKKSGCGRQ | 141 | Q92185 | |
| GNKVFGALKGAVDGG | 156 | P46777 | |
| SLGDVKGNGKGGFVL | 151 | Q13228 | |
| KGNGKGGFVLLDGET | 156 | Q13228 | |
| EIGGGAEGGQGKRKR | 16 | Q15543 | |
| KDGLVAGSGQEGTRG | 831 | Q9Y2I6 | |
| GLAGGKARGAGATGK | 96 | P47972 | |
| GKILGICGNVGSGKS | 506 | Q96J65 | |
| QKPGAKGCEGRSGDG | 1171 | Q99466 | |
| KELRAGKGNGEGGVG | 401 | A0A1B0GV85 | |
| RGKGTFESGLKGGVK | 106 | Q9P2R7 | |
| QKKEDTGGGGRSAGQ | 206 | Q9H2D6 | |
| KGGNSEIKRIGGLGS | 756 | P63128 | |
| GQKIGICGRTGSGKS | 1371 | Q09428 | |
| GSGDGRIVIAAAKKG | 96 | Q6P4H8 | |
| TGKQEGAKLLCGGGI | 376 | P05091 | |
| GEKGGDSFGVQIKGA | 71 | Q9P2M7 | |
| GNGTRGTGGVGDKRQ | 151 | Q9Y4C5 | |
| AAGHKLGAKKEGVGG | 371 | Q9Y4C5 | |
| KGAAGEPGKAGERGV | 586 | P02452 | |
| KGETGEQGDRGIKGH | 1096 | P02452 | |
| EGLKGEVGDQGNIGK | 836 | Q17RW2 | |
| KEGEGLGSEGQGIKN | 576 | Q8IWZ8 | |
| AGGGGAAKTGIKNGV | 31 | Q9HCU5 | |
| KKGDSVGLRLAGGND | 516 | Q9UDY2 | |
| AELTGRKGGCAKGKG | 136 | P08559 | |
| QQVSGLMDGKGGGKD | 921 | P49588 | |
| GRGLGLSIVGKRNGS | 1541 | Q8NI35 | |
| VKTRNKALGVAVGGG | 16 | Q9P2W9 | |
| TKVYVGNLGTGAGKG | 11 | Q16629 | |
| GNLGTGAGKGELERA | 16 | Q16629 | |
| LGKGETQGLLTAKGG | 226 | Q8IX01 | |
| AKVARKGGGLAGVGG | 491 | Q8N9M5 | |
| GGGLGGKKESGQLRF | 141 | Q16560 | |
| RIKVNGKAGNLGGGV | 46 | P35268 | |
| KDPGVGGKARAGAGA | 526 | Q9NNW5 | |
| AGYLKNTKGGGLEGR | 1636 | Q4KWH8 | |
| ESGKGKGIAGRQDIL | 141 | Q9BW30 | |
| KADGRAGLGTGGQKV | 451 | Q8N1G0 | |
| RRGVGKASALGLGDG | 1161 | Q8N1G0 | |
| KLVVVGGGGVGKSAL | 31 | P10301 | |
| GGGKLRKNSEAGGAG | 61 | Q5VZ18 | |
| KAAATAGGQGGAARK | 111 | P50607 | |
| GGVAGGSILKGVLKV | 276 | P41091 | |
| GTAISGGKAEGEKGR | 1276 | O14686 | |
| KGLSATVTGGQKGRG | 111 | P60201 | |
| DGVNKGRGGKGSIYV | 291 | P16519 |